Document:

<Page>

                                                                    Exhibit 10.3

                           EMPLOYEE BENEFITS AGREEMENT

                                  BY AND AMONG

                              ABBOTT LABORATORIES,

                        TAP PHARMACEUTICAL PRODUCTS INC.

                                       AND

                                  HOSPIRA, INC.

                                      DATED

                                 ________, 2004

                                        1
<Page>

                                TABLE OF CONTENTS

<Table>
<Caption>
                                                                                 Page
                                                                                 ----
<S>                                                                                <C>
Article 1 Definitions...............................................................4

Article 2 General Principles........................................................9

2.1        Allocation of Liabilities................................................9

2.2        Employment with Hospira.................................................11

2.3        Establishment of Hospira Plans..........................................13

2.4        Restrictions on Employment..............................................14

2.5        Post-Distribution Transferred Employees and Hospira Requested
                Employees..........................................................14

Article 3 Collective Bargaining Agreements and Union Matters.......................15

Article 4 U.S. Qualified and Non-Qualified Retirement Plans........................15

4.1        Annuity Retirement Plan.................................................15

4.2        Stock Retirement Plan...................................................18

4.3        Faultless Rubber Plan...................................................20

4.4        Ashland 401(k) Plan.....................................................20

4.5        Supplemental Pension Plan...............................................21

4.6        Abbott Supplemental 401(k) Plan.........................................22

Article 5 Non-U.S. Retirement Plans................................................22

5.1        Canadian Pension Plan...................................................22

5.2        Irish Pension Plans.....................................................23

5.3        Overseas Managers' Pension Plan.........................................23

5.4        Other Non-U.S. Retirement Plans.........................................24

Article 6 Welfare and Fringe Benefit Plans.........................................24

6.1        Severance Compensation and Benefits.....................................24

6.2        Retiree Medical And Life Insurance Coverage.............................25

6.3        VEBAs ..................................................................26

6.4        COBRA ..................................................................26

6.5        Matching Grant and Combined Appeal Programs.............................26

Article 7 Equity and Executive Compensation Programs...............................27

7.1        Equity Incentive Programs...............................................27

7.2        Discontinued Participation in ESPP......................................28
</Table>

                                        2
<Page>

<Table>
<S>                                                                                <C>
7.3        Deferred Compensation Plan..............................................29

7.4        Grantor Trusts..........................................................29

7.5        Cash Profit Sharing.....................................................30

7.6        Other Incentive Programs................................................30

Article 8 Miscellaneous............................................................31

8.1        Transfer of Records and Information ....................................31

8.2        Preservation of Rights to Amend or Terminate Plans......................31

8.3        Transition Services.....................................................32

8.4        Reimbursement...........................................................32

8.5        Clara Abbott Foundation.................................................32

8.6        Incorporation By Reference..............................................32

8.7        Limitation on Enforcement...............................................32

8.8        Assignability...........................................................32

8.9        Further Assurances and Consents.........................................33

8.10       Third Party Consent.....................................................33

8.11       Effect if Distribution Does not Occur...................................33

8.12       Disputes................................................................34

8.13       Schedules...............................................................34

8.14       Mutual Drafting.........................................................34
</Table>

                                        3
<Page>

                           EMPLOYEE BENEFITS AGREEMENT

     This Employee Benefits Agreement (this "Agreement") is made as of
_____, 2004 by and among Abbott Laboratories ("Abbott"), Hospira, Inc.
("Hospira") and, solely for purposes of Sections 2.4, 8.7, and 8.8, TAP
Pharmaceutical Products Inc. ("TAP").

                                   BACKGROUND

     Abbott and Hospira have entered into the Separation and Distribution
Agreement (as defined herein) pursuant to which Abbott shall spin-off the
Hospira Business (as defined herein). Abbott shall accomplish this spin-off by
distributing all of the common stock of Hospira to the shareholders of Abbott as
a dividend after Abbott contributes to Hospira the assets primarily associated
with the Hospira Business and after Hospira assumes the liabilities primarily
associated with the Hospira Business, all in accordance with the Separation and
Distribution Agreement and agreements related thereto, including this Agreement.
After the Distribution (as defined herein), Abbott and Hospira shall be separate
and independent corporations.

     The employees of the Hospira Business are currently employed by the Abbott
Group (as defined herein). The employees of the Hospira Business are expected to
become employees of the Hospira Group (as defined herein) on or prior to the
Distribution Date or with respect to certain employees outside of the United
States, after the Distribution Date. This Agreement describes the employment and
the employee benefit plan arrangements that shall apply to Transferred Employees
(as defined herein). Additional information relating to agreements of Abbott and
Hospira with respect to Transferred Employees are included in the Transition
Services Agreements.

                                    AGREEMENT

                                    ARTICLE 1

                                   DEFINITIONS

     The following capitalized terms as used in this Agreement shall have the
meaning set forth below unless otherwise specified herein:

                (a)    "Abbott" shall have the meaning given it in the first
sentence of this Agreement.

                (b)    "Abbott ARP" shall mean the Abbott Laboratories Annuity
Retirement Plan.

                (c)    "Abbott Benefit Plan" shall mean each Benefit Plan
established, maintained, or contributed to by the Abbott Group for the benefit
of Transferred Employees.

                                        4
<Page>

                (d)    "Abbott Compensation Committee" shall mean the
compensation committee of the board of directors of Abbott.

                (e)    "Abbott DCP" shall mean the Abbott Laboratories Deferred
Compensation Plan.

                (f)    "Abbott ESPP" shall mean the Abbott Laboratories
Affiliate Employee Stock Purchase Plan and any sub-plan established thereunder
in accordance with the laws of any non-U.S. jurisdiction.

                (g)    "Abbott Group" shall mean Abbott and its Subsidiaries
(excluding any member of the Hospira Group after the Distribution) or, where the
context requires, a company within the Abbott Group.

                (h)    "Abbott KSP" shall mean the Abbott Laboratories 401(k)
Supplemental Plan.

                (i)    "Abbott OMPP" shall mean the Overseas Managers' Pension
Plan of Abbott Laboratories.

                (j)    "Abbott Option" shall mean an option to purchase one or
more Abbott common shares granted under the Abbott Stock Programs.

                (k)    "Abbott Retained Employee" shall mean any employee other
than (i) a Transferred Employee or (ii) a Hospira Requested Employee.

                (l)    "Abbott Retiree Life Plan" shall mean the Abbott
Laboratories Retiree Life Plan.

                (m)    "Abbott Retiree Medical Plan" shall mean the Abbott
Laboratories Retiree Health Care Plan.

                (n)    "Abbott SRP" shall mean the Abbott Laboratories Stock
Retirement Plan (Part A).

                (o)    "Abbott Stock Programs" shall mean, collectively, the
Abbott Laboratories 1996 Incentive Stock Program, the Abbott Laboratories 1991
Incentive Stock Program, and any sub-plan established under those programs in
accordance with the laws of any non-U.S. jurisdiction.

                (p)    "Abbott Supplemental ARP" shall mean the Abbott
Laboratories Supplemental Pension Plan.

                (q)    "Abbott VEBAs" shall mean, collectively, the Abbott
Laboratories Employee Benefit Trust, the Abbott Laboratories Health Care Trust,
and the Abbott Laboratories Employees Insurance Trust.

                                        5
<Page>

                (r)    "ABO Funded Ratio" shall have the meaning given it in
Section 4.1(c) of this Agreement.

                (s)    "Allocated Employee Number" shall mean, with respect to
any country identified on Schedule 1 hereto, the number of Employees shown on
Schedule 1 opposite that country's name as being the number of Employees to be
transferred to the Hospira Group.

                (t)    "Ashland 401(k) Plan" shall mean the Abbott Laboratories
Ashland Union 401(k) Plan and Trust.

                (u)    "Benefit Plan" shall mean, any employment, bonus,
deferred compensation, incentive compensation, stock purchase, stock option,
stock appreciation right or other stock-based incentive, severance,
change-in-control or termination pay, hospitalization or other medical,
disability, life, or other insurance, supplemental unemployment benefits,
profit-sharing, pension or retirement plan, program, agreement, or arrangement
and each other employee benefit plan, program, agreement, or arrangement.

                (v)    "COBRA" shall mean coverage required by Section 4980B of
the Code and regulations thereunder or Section 601 et. seq. of ERISA.

                (w)    "Code" shall mean the Internal Revenue Code of 1986, as
amended.

                (x)    "Distribution" shall have the meaning given it in the
Separation and Distribution Agreement.

                (y)    "Distribution Date" shall have the meaning given it in
the Separation and Distribution Agreement.

                (z)    "Employee" shall mean any individual who is (i)
identified or described on Schedule 2 hereto, (ii) a Post-Distribution Employee,
or (iii) a Hospira Requested Employee.

                (aa)   "Employment Taxes" shall mean withholding, payroll,
social security, workers compensation, unemployment, and disability taxes
imposed by any Tax Authority, and any interest, penalties, additions to tax, or
additional amount with respect to the foregoing imposed on any taxpayer or
consolidated, combined, or unitary group of taxpayers.

                (bb)   "ERISA" shall mean the Employee Retirement Income
Security Act of 1974, as amended.

                (cc)   "ESOP" shall mean an employee stock ownership plan, as
defined in Section 407(d)(6) of ERISA and Section 4975(e)(7) of the Code.

                                        6
<Page>

                (dd)   "Faultless Rubber Plan" shall mean the 1950 Pension Plan
of the Faultless Rubber Company and the Pension, Insurance and Severance Award
Agreement.

                (ee)   "Hospira" shall have the meaning given it in the first
sentence of this Agreement.

                (ff)   "Hospira ARP" shall mean the Abbott/Hospira Transitional
Annuity Retirement Plan.

                (gg)   "Hospira Benefit Plan" shall mean any Benefit Plan
established, maintained, or contributed to by the Hospira Group.

                (hh)   "Hospira Board" shall mean the board of directors of
Hospira.

                (ii)   "Hospira Business" shall have the meaning given it in the
Separation and Distribution Agreement.

                (jj)   "Hospira Canadian Pension Plan" shall mean a defined
benefit pension plan established by the Hospira Group with respect to employees
of Hospira residing in Canada.

                (kk)   "Hospira Group" shall mean Hospira and its Subsidiaries
or, where the context requires, a company within the Hospira Group.

                (ll)   "Hospira KSP" shall mean the Hospira 401(k) Supplemental
Plan.

                (mm)   "Hospira Officer" shall mean each Transferred Employee
who is a "reporting officer" under Rule 16a-1(f) under the Securities Exchange
Act of 1934.

                (nn)   "Hospira OMPP" shall mean the Overseas Managers' Pension
Plan of Hospira, Inc.

                (oo)   "Hospira Option" shall mean an option to purchase one or
more shares of Hospira common stock granted under the Hospira SIP in connection
with the cancellation of an Abbott Option.

                (pp)   "Hospira Requested Employee" shall mean any employee of
the Abbott Group who was hired or transferred to another work location or
position by the Abbott Group prior to, on, or following the Distribution Date,
at the written request of Hospira's Corporate Vice President of Human Resources,
regardless of whether that employee becomes a Transferred Employee.

                (qq)   "Hospira SIP" shall mean the Hospira 2004 Long-Term Stock
Incentive Plan.

                                        7
<Page>

                (rr)   "Hospira SRP" shall mean the Hospira 401(k) Retirement
Savings Plan.

                (ss)   "Hospira Supplemental ARP" shall mean the Hospira
Supplemental Pension Plan.

                (tt)   "Hospira VEBA" shall mean the Hospira Master Welfare
Trust.

                (uu)   "KSP Transferred Employee" shall mean a U.S. Transferred
Employee who participates in the Abbott KSP immediately prior to the
Distribution Date.

                (vv)   "Liabilities" shall have the meaning given it in the
Separation and Distribution Agreement.

                (ww)   "Non-U.S. Transferred Employee" shall mean a Transferred
Employee who works primarily outside of the United States or who works primarily
in Puerto Rico.

                (xx)   "Post-Distribution Employee" shall mean each sales or
marketing employee of the Abbott Group identified by Abbott and Hospira in
accordance with Step 1 of the procedures described in Schedule 3 hereto.

                (yy)   "Post-Distribution Transferred Employee" shall mean any
Post-Distribution Employee who becomes a Transferred Employee after the
Distribution Date but prior to the end of the Restricted Period.

                (zz)  "QDRO" shall mean a qualified domestic relations order
within the meaning of Section 206(d) of ERISA and Section 414(p) of the Code.

                (aaa)  "Request End Date" shall mean, with respect to any
Hospira Requested Employee, the earliest, if any, of the following dates: (i)
the date on which Hospira provides notice to Abbott that Hospira does not intend
to employ the Hospira Requested Employee, (ii) the date on which Hospira
provides notice to Abbott that the Hospira Requested Employee has rejected an
offer of employment with the Hospira Group, or (iii) the date following the
expiration of the Restricted Period in the event that the Hospira Requested
Employee remains employed by the Abbott Group on that date.

                (bbb)  "Restricted Period" shall mean the period beginning on
the Distribution and ending on the second anniversary thereof.

                (ccc)  "Separation and Distribution Agreement" shall mean the
Separation and Distribution Agreement by and between Abbott Laboratories and
Hospira, Inc. dated _____________.

                                        8
<Page>

                (ddd)  "Subsidiary" shall have the meaning given it in the
Separation and Distribution Agreement.

                (eee)  "TAP" shall have the meaning given it in the first
sentence of this Agreement.

                (fff)  "Tax Authority" means, with respect to any Employment
Tax, the governmental entity or political subdivision thereof that imposes such
Employment Tax, and the agency (if any) charged with the collection of such
Employment Tax for such entity or subdivision.

                (ggg)  "Transfer Date" shall mean, as applicable: (i) with
respect to each Transferred Employee (other than a Post-Distribution Transferred
Employee or a Hospira Requested Employee), the Distribution Date; and (ii) with
respect to each Post-Distribution Transferred Employee and each Hospira
Requested Employee, the date on which such person becomes employed by the
Hospira Group.

                (hhh)  "Transferred Employee" shall mean an Employee who accepts
an offer of employment with the Hospira Group or who continues in employment
automatically by operation of law with the Hospira Group, in either case
pursuant to Section 2.2 or 2.5 of this Agreement.

                (iii)  "Transferred Expatriate Employee" shall mean each
Employee identified on Schedule 4 hereto who becomes a Transferred Employee.

                (jjj)  "Transition Period" shall mean the period beginning on
the Distribution and ending on December 31, 2004.

                (kkk)  "Transition Services Agreements" shall mean the
transition services agreements and the transition marketing and distribution
agreements that are entered into in connection with the Separation and
Distribution Agreement between Abbott and Hospira.

                (lll)  "U.S. Transferred Employee" shall mean a Transferred
Employee who works primarily in the United States (other than a Transferred
Employee who works in Puerto Rico).

                                    ARTICLE 2

                               GENERAL PRINCIPLES

          2.1   ALLOCATION OF LIABILITIES.

                (a) HOSPIRA LIABILITIES. Effective as of Distribution Date, and
except as expressly provided in this Agreement, Hospira hereby assumes and
agrees to pay, perform, fulfill and discharge all Liabilities to the extent
relating to, arising out of, or resulting from:

                                        9
<Page>

                       (i)    the employment of each Transferred Employee by the
     Abbott Group up to and including the Transfer Date and by the Hospira Group
     on and after the Transfer Date (including, in each case, all Liabilities
     relating to, arising out of, or resulting from Employment Taxes, any Abbott
     Benefit Plan or, on or after the Transfer Date, any Hospira Benefit Plan);

                       (ii)   the transfer of any Transferred Employee's
     employment from the Abbott Group to the Hospira Group;

                       (iii)  all Liabilities (including Liabilities with
     respect to employees, former employees and retirees) relating to, arising
     out of or resulting from the Faultless Rubber Plan and the Ashland 401(k)
     Plan.

                       (iv)   the employment (or termination of employment) of
     any Hospira Requested Employee by the Abbott Group prior to, on, or after
     the Distribution Date (including all Liabilities to the extent relating to,
     arising out of, or resulting from Employment Taxes or any Abbott Benefit
     Plan) subject to Section 2.5(b) of this Agreement; and

                       (v)    obligations, Liabilities and responsibilities
     expressly assumed by Hospira pursuant to this Agreement.

                (b) ABBOTT LIABILITIES. Effective as of the Distribution Date,
and except as expressly provided in this Agreement, Abbott shall retain and
hereby agrees to pay, perform, fulfill and discharge all Liabilities to the
extent relating to, arising out of, or resulting from:

                       (i)    the employment (or termination of employment) of
     each Abbott Retained Employee by the Abbott Group prior to, on, or after
     the Distribution Date (including all Liabilities to the extent relating to,
     arising out of, or resulting from Employment Taxes or any Abbott Benefit
     Plan);

                       (ii)   the employment, whether prior to, on, or after the
     Distribution Date, by the Abbott Group of all persons who work or worked
     primarily in the United States (other than Puerto Rico) and who are
     deceased, retired, terminated, on pay continuation leave, or on medical
     leave of absence for more than one year (including all Liabilities to the
     extent relating to, arising out of, or resulting from Employment Taxes or
     any Abbott Benefit Plan);

                       (iii)  medical and dental claims which are incurred by
     any U.S. Transferred Employee (or his or her beneficiaries) prior to the
     Transfer Date;

                                       10
<Page>

                       (iv)   obligations, Liabilities and responsibilities
     under (A) the Abbott Retiree Medical Plan and the Abbott Retiree Life Plan
     for retirement eligible Transferred Employees (as more fully described in
     Section 6.2 of this Agreement), (B) the Abbott DCP (as more fully described
     in Section 7.3 of this Agreement), and (C) the grantor trusts of
     Transferred Employees (as more fully described in Section 7.4 of this
     Agreement); and

                       (v)    obligations, Liabilities and responsibilities
     expressly retained by Abbott pursuant to this Agreement.

          2.2   EMPLOYMENT WITH HOSPIRA.

                (a) OFFERS OF EMPLOYMENT. As of the Distribution Date, the
Hospira Group shall continue the employment (on a basis consistent with
subsection (b) below) of each Employee (who is not a Post-Distribution Employee
or a Hospira Requested Employee) in jurisdictions where employment continues
automatically by operation of law, and shall offer to employ (on a basis
consistent with subsection (b) below) each other Employee (who is not a
Post-Distribution Employee or a Hospira Requested Employee), or as otherwise
agreed by the parties. The parties acknowledge that the process of transferring
Employees to the Hospira Group may, as agreed upon by the parties, in certain
cases, begin prior to the Distribution Date. Abbott shall use commercially
reasonable efforts to ensure that no Employee's transfer of employment to
Hospira prior to the Distribution Date will cause a loss of coverage under any
Abbott Benefit Plan prior to the Distribution Date.

          Post-Distribution Employees shall be offered employment by the Hospira
Group, or shall continue to be employed by the Hospira Group, as the case may
be, as determined by Abbott and Hospira in accordance with Section 2.5(a) of
this Agreement and the procedures described in Schedule 3 hereto and effective
at such time or times as determined in accordance with those procedures. To the
extent any dispute arises pursuant to this paragraph, including with respect to
the procedures described in that Schedule 3, that dispute shall be resolved by
mutual written agreement between the Chief Executive Officers of Abbott and
Hospira (or their designees).

          Hospira Requested Employees (who are not Post-Distribution Employees)
shall be offered employment by the Hospira Group, or shall continue to be
employed by the Hospira Group, as the case may be, as determined by Abbott and
Hospira, subject to Section 2.5(b) of this Agreement.

                (b) COMPENSATION AND BENEFITS. Except as expressly provided in
this Agreement, no Transferred Employee shall participate in the Abbott Benefit
Plans following his or her Transfer Date. After the Transfer Date, the Hospira
Group may provide compensation and benefits to a U.S. Transferred Employee or
Transferred Expatriate Employee under any Hospira Benefit Plan. Except as
expressly provided in this Agreement, during the Transition Period, the Hospira
Group shall provide benefits (e.g., pension and welfare benefits) to each U.S.
Transferred Employee and each

                                       11
<Page>

Transferred Expatriate Employee that are substantially similar to the benefits
provided to that U.S. Transferred Employee or Transferred Expatriate Employee
immediately prior to the Transfer Date. During the Transition Period, the
Hospira Group shall provide each U.S. Transferred Employee and each Transferred
Expatriate Employee with base compensation (including salary and hourly rate)
that is not less than the compensation provided to that U.S. Transferred
Employee or Transferred Expatriate Employee immediately prior to the Transfer
Date, provided, however, that the compensation of each Hospira Officer may be
adjusted by the Hospira Board (or an appropriate committee thereof) without
regard to the Hospira Officer's compensation immediately prior to the Transfer
Date. During the Transition Period, the Hospira Group shall make all scheduled
increases to any U.S. Transferred Employee's or Transferred Expatriate
Employee's salary or hourly rate to the extent that the scheduled increase is
not already reflected in any prior discretionary increase made by the Hospira
Group to that salary or hourly rate. The Hospira Group shall not reduce any U.S.
Transferred Employee's or Transferred Expatriate Employee's salary or hourly
rate during the Transition Period other than: (i) the salaries of Hospira
Officers as determined by the Hospira Board (or an appropriate committee
thereof) or (ii) reductions corresponding to a change in the affected
Transferred Employee's circumstances and made in the ordinary course of business
(including, but not limited to, reductions in connection with shift changes,
schedule changes, demotions, job changes and job performance). Nothing in the
preceding sentence shall prevent the Hospira Group from terminating the
employment of any U.S. Transferred Employee or Transferred Expatriate Employee,
whether due to individual terminations of employment or reductions in force or
otherwise, in all cases in compliance with applicable law.

          After expiration of the Transition Period, the Hospira Group may
implement compensation and benefits for the U.S. Transferred Employees and
Transferred Expatriate Employees as it deems appropriate; provided, however,
that the Hospira Group shall repatriate a Transferred Expatriate Employee to his
or her home or jurisdiction on terms no less favorable than the terms under the
Transferred Expatriate Employee's written employment/expatriate agreement with
Abbott as in effect immediately prior to the Transfer Date.

          The Hospira Group shall employ each Non-U.S. Transferred Employee
(other than Transferred Expatriate Employees) on such terms and conditions as
the Hospira Group deems necessary or advisable, except where otherwise required
by local law.

                (c) SERVICE CREDIT. Except as expressly provided in this
Agreement, during the Transition Period, for purposes of determining
eligibility, vesting, accrued benefits, and benefit level, each of the Hospira
Benefit Plans shall give U.S. Transferred Employees and Transferred Expatriate
Employees credit for all service credited for those purposes by the comparable
Abbott Benefit Plan as of the Transfer Date, except to the extent that this
service credit would result in a duplication of benefits. For the avoidance of
doubt, nothing in this Agreement shall require the Hospira Group to provide any
U.S. Transferred Employee or Transferred Expatriate Employee with credit for his
or her service with the Abbott Group (i) under any Hospira Benefit Plan after
the

                                       12
<Page>

Transition Period or (ii) under any Hospira Benefit Plan that does not have a
comparable Abbott Benefit Plan during the Transition Period.

                (d) VACATION, HOLIDAYS AND LEAVES OF ABSENCE. In accordance with
Section 2.1(a)(i) of this Agreement, effective as of the Transfer Date, Hospira
shall assume all Liabilities of the Abbott Group with respect to accrued
vacation or leaves of absence, and required payments related thereto, for each
Transferred Employee.

          Notwithstanding the foregoing, where (and only to the extent) required
by applicable state law, the Abbott Group shall provide each U.S. Transferred
Employee with the opportunity to elect to receive a payment of his or her
accrued vacation as of the Transfer Date, the Abbott Group shall pay that
accrued vacation to any such individual who elects to receive a payment and the
Hospira Group shall not assume any accrued vacation or receive the accrual with
respect to a U.S. Transferred Employee who elects a payment in accordance with
the foregoing.

          During the Transition Period, the Hospira Group shall continue to
apply the vacation, holiday and leave of absence policy or practice (whether or
not legally required) applicable to each U.S. Transferred Employee and each
Transferred Expatriate Employee immediately prior to the Transfer Date so that
each U.S. Transferred Employee and each Transferred Expatriate Employee shall be
entitled to use any vacation time or leave of absence, and/or receive any pay
related thereto, to which that Employee would otherwise be entitled under the
Abbott Benefit Plans related to vacation time or leave of absence as of the
Transfer Date, taking into account, to the extent applicable, any reduction in
vacation time for which any U.S. Transferred Employee has received a payment of
accrued vacation as of the Transfer Date.

          Vacation, holiday and leave of absence policies for Transferred
Employees for periods after the Transition Period shall be determined by Hospira
in its sole discretion.

          2.3   ESTABLISHMENT OF HOSPIRA PLANS.

          Prior to the Distribution Date, Hospira shall adopt the following
employee benefit plans and their related trusts: (a) the Hospira SIP, (b) the
Hospira ARP, (c) the Hospira SRP, (d) the Hospira Health Care Plan, and (e) the
Hospira Life Accident Plan. Hospira shall also adopt (i) the Hospira
Supplemental ARP, (ii) the Hospira KSP, (iii) the Hospira Flexible Benefit Plan,
(iv) the Hospira Extended Disability Plan, and (v) the Hospira OMPP, none of
which shall have a related trust unless Hospira elects, in its sole and absolute
discretion, to establish a rabbi trust or other trust for any of those plans.
During the Transition Period, each of the foregoing Hospira Benefit Plans,
except as expressly provided in this Agreement, shall be substantially similar
in all material respects to the corresponding Abbott Benefit Plan as in effect
as of the Distribution Date. As more fully described in Articles 4, 5 and 6 or
as otherwise mutually agreed upon by Abbott and Hospira from time to time,
Abbott shall, or shall cause the applicable Abbott Benefit Plan's related trust
to, transfer to the relevant Hospira Benefit Plan's related trust, amounts equal
to trust assets, insurance reserves, and other related assets of each Abbott

                                       13
<Page>

Benefit Plan's related trust relating to the Liabilities of such Abbott Benefit
Plan assumed by Hospira or such Hospira Benefit Plan. As more fully described in
Articles 4, 5 and 6, or as otherwise mutually agreed upon by Abbott and Hospira
from time to time, Hospira shall, or shall cause the relevant Hospira Benefit
Plan to, assume the Liabilities of the corresponding Abbott Benefit Plan with
respect to all benefits accrued under that Abbott Benefit Plan by Transferred
Employees prior to the Transfer Date. Except as expressly provided in this
Agreement, after the Transition Period, Hospira may modify or terminate any
Hospira Benefit Plan, as it deems appropriate.

          Hospira shall cause the Hospira Benefit Plans to honor all plan
elections made by Transferred Employees pursuant to corresponding Abbott Benefit
Plans. Except as provided in this Agreement, Abbott and Hospira shall use
commercially reasonable efforts to ensure that the Distribution and the transfer
of any Transferred Employee's employment to the Hospira Group will not entitle
that Transferred Employee to a distribution or payment of benefits under any
Abbott Benefit Plan.

          2.4   RESTRICTIONS ON EMPLOYMENT.

          Hospira agrees that, during the Restricted Period and without the
express written consent of Abbott or TAP, as applicable, it shall not, and shall
not permit any of its Subsidiaries to, employ any person, other than a
Transferred Employee, who is or was an employee of Abbott or TAP (or their
respective Subsidiaries) and whose employment with Abbott and/or TAP (and/or
their respective Subsidiaries) terminated at any time after August 22, 2003 and
before the last day of the Restricted Period. Abbott and TAP each agree that,
during the Restricted Period and without the express written consent of Hospira,
each shall not, and shall not permit any of their respective Subsidiaries to,
employ any person who is a Transferred Employee or any other person who becomes
an employee of Hospira or any of its Subsidiaries prior to the expiration of the
Restricted Period. The foregoing restrictions shall not apply to any person
(other than a Post-Distribution Employee who rejects an offer of employment from
the Hospira Group) whose employment with Hospira, Abbott or TAP (or their
respective Subsidiaries), as applicable, terminates due to a job elimination or
reduction in force.

          2.5   POST-DISTRIBUTION TRANSFERRED EMPLOYEES AND HOSPIRA REQUESTED
EMPLOYEES.

                (a) TRANSFER DATE FOR POST-DISTRIBUTION TRANSFERRED EMPLOYEES.
The Transfer Date of each Post-Distribution Transferred Employee shall be
determined by Abbott and Hospira, provided that in no event shall the Transfer
Date of any Post-Distribution Transferred Employee occur following the
Restricted Period. Unless otherwise determined by Abbott and Hospira or
otherwise required by local law, all Post-Distribution Transferred Employees and
Hospira Requested Employees working primarily in the same country shall have the
same Transfer Date.

                (b) HOSPIRA REQUESTED EMPLOYEES. As soon as practicable
following the Request End Date of any Hospira Requested Employee, Abbott shall
either terminate the employment of that Hospira Requested Employee or notify
Hospira that the

                                       14
<Page>

Abbott Group intends to continue to employ the Hospira Requested Employee
following the Request End Date. Notwithstanding Section 2.1(a)(iv) of this
Agreement, in the event that Abbott notifies Hospira that the Abbott Group will
continue to employ a Hospira Requested Employee following Request End Date,
Abbott shall retain all Liabilities relating to, arising out of, or resulting
from the employment (or termination of employment) of that Hospira Requested
Employee on and following the Request End Date, provided that Abbott and Hospira
shall negotiate to apportion those Liabilities arising in part both before and
after the Request End Date.

                                    ARTICLE 3

               COLLECTIVE BARGAINING AGREEMENTS AND UNION MATTERS

          Hospira shall assume all Liabilities with respect to or arising under
any collective bargaining agreements with respect to U. S. Transferred Employees
in Ashland, Ohio.

                                    ARTICLE 4

                U.S. QUALIFIED AND NON-QUALIFIED RETIREMENT PLANS

          4.1   ANNUITY RETIREMENT PLAN.

                (a) ESTABLISHMENT OF HOSPIRA ARP. Effective on or before the
Distribution Date, Hospira shall establish the Hospira ARP, which, for the
Transition Period, shall provide for a benefit formula that is substantially
similar in all material respects to the benefit formula in effect under the
Abbott ARP as of the Distribution Date. As soon as practicable after the
Distribution Date and upon receipt by Abbott of (i) copies of the Hospira ARP;
(ii) copies of certified resolutions of the Hospira Board (or its authorized
committee or other delegate) evidencing adoption of the Hospira ARP and the
related trust(s) and the assumption by the Hospira ARP of the Liabilities set
forth in Section 4.1(d) of this Agreement; and (iii) either (A) a favorable
determination letter issued by the Internal Revenue Service with respect to the
Hospira ARP and its related trust, or (B) an opinion of Hospira's counsel, which
opinion is reasonably satisfactory to Abbott's counsel, with respect to the
qualified status of the Hospira ARP under Section 401(a) of the Code and the
tax-exempt status of its related trust under Section 501(a) of the Code, Abbott
shall direct the trustee of the Abbott ARP to transfer from the trust(s) which
forms a part of the Abbott ARP to the trust(s) which forms a part of the Hospira
ARP the amounts described in Section 4.1(b) of this Agreement.

                (b) ERISA SECTION 4044 TRANSFER. The amount of assets to be
transferred from the Abbott ARP to the Hospira ARP shall be determined as of the
Distribution Date in accordance with Section 4044 of ERISA and shall comply in
all respects with Sections 414(l) of the Code. Assumptions not specifically
dictated by Section 4044 of ERISA shall be based on the assumptions used in the
report prepared by Hewitt Associates entitled Actuarial Report Abbott
Laboratories Annuity Retirement Plan as of January 1, 2003 (signed October
2003). The Hospira ARP shall receive a pro-rata

                                       15
<Page>

share of any contributions made to the Abbott ARP after the Distribution Date
but on behalf of the 2003 plan year. The pro-rata share of the contributions for
the Hospira ARP shall be determined as if the 2003 plan year contribution had
been part of the Abbott ARP's assets at the time the asset allocation was
performed. The transfer amount described above shall be credited or debited, as
applicable, with a pro rata share of the actual investment earnings or losses
allocable to the transfer amount for the period between the Distribution Date
and an assessment date set by Abbott that is no more than ten (10) days prior to
the date upon which assets are actually transferred from the Abbott ARP to the
Hospira ARP. During this time, benefits for U.S. Transferred Employees who
terminate employment with the Hospira Group shall be paid from the Abbott ARP.
The ultimate transfer amount shall be reduced by the amount of these benefits
and credited or debited by the actual investment earnings or losses from the
payment date to the assessment date set by Abbott above. In addition, during
this time, Hospira will be responsible for a pro rata share of trustee and
administration fees to the extent included in the Abbott ARP's trust expenses.
The entries in the Abbott ARP funding standard account shall be divided between
the two plans based on the guidance provided in Revenue Ruling 81-212.

                (c) ADDITIONAL TRANSFER. In addition to, and within sixty (60)
days following, the transfer of assets from the Abbott ARP to the Hospira ARP
described in Section 4.1(b) of this Agreement, Abbott shall pay Hospira an
amount equal to that amount which, if contributed by Hospira to the Hospira ARP
immediately following the transfer of assets required by Section 4.1(b) of this
Agreement, would cause the ABO Funded Ratio of the Hospira ARP and the Abbott
ARP to be equivalent as of the Distribution Date. With respect to a plan, the
ABO Funded Ratio shall equal the fair market value of assets of that plan
divided by the Accumulated Benefit Obligation of that plan, as determined under
FAS 87. In calculating the ABO Funded Ratio, the assets for the Hospira ARP
shall include the amount transferred directly from the Abbott ARP in accordance
with Section 4.1(b) of this Agreement and the amount to be paid by Abbott in
accordance with this Section 4.1(c). The pro-rata share of the 2003 plan year
contributions assigned to the Abbott ARP in 4.1(b), that are contributed
following the Distribution Date, shall be taken into account for purposes of
calculating the ABO Funded Ratio of the Abbott ARP as of the Distribution Date
as if those contributions had been part of the assets of the Abbott ARP on the
Distribution Date. Similarly, the pro-rata share of the 2003 plan year
contributions assigned to the Hospira ARP in Section 4.1(b) of this Agreement,
that are contributed following the Distribution Date, shall be taken into
account for purposes of calculating the ABO Funded Ratio of the Hospira ARP as
of the Distribution Date as if those contributions had been part of the assets
of the Hospira ARP on the Distribution Date. With the exception of the discount
rate, the Accumulated Benefit Obligation shall be calculated using the
assumptions and methodology used to calculate Abbott's December 31, 2003, FAS 87
disclosure information. The discount rate shall be determined as of the
Distribution Date using Abbott's FAS 87 discount rate setting methodology
consistent with Abbott's past practices. Hospira shall not be required to
reimburse Abbott for any tax benefit received by Hospira with respect to any
contribution to the Hospira ARP.

                                       16
<Page>

                (d) TRANSFERRED ARP LIABILITIES. As of the Distribution Date,
Hospira shall cause the Hospira ARP to assume all Liabilities under the Abbott
ARP for U.S. Transferred Employees (including Liabilities in respect of QDROs
established in relation to U.S. Transferred Employees) and the Abbott ARP shall
be relieved of all such Liabilities; provided, however that the Abbott ARP shall
continue to pay benefits associated with those Liabilities until assets are
transferred from the Abbott ARP to the Hospira ARP in accordance with this
Section 4.1.

                (e) HOSPIRA ARP DURING THE TRANSITION PERIOD.  During the
Transition Period (and thereafter to the extent required by applicable law), the
Hospira ARP shall provide that:

                       (i)    U.S. Transferred Employees shall (A) be eligible
     to participate in the Hospira ARP to the extent they were eligible to
     participate in the Abbott ARP as of the Distribution Date, and (B) receive
     credit for vesting, eligibility and benefit service for all service
     credited for those purposes under the Abbott ARP as of the Distribution
     Date as if that service had been rendered to Hospira;

                       (ii)   the compensation paid by the Abbott Group to all
     U.S. Transferred Employees which is recognized under the Abbott ARP as of
     the Distribution Date shall be credited and recognized for all applicable
     purposes under the Hospira ARP as though it were compensation from the
     Hospira Group;

                       (iii)  subject to applicable law, the accrued benefit of
     each U.S. Transferred Employee under the Abbott ARP as of the Distribution
     Date shall be paid under the Hospira ARP at the time and in a form that
     would have been permitted under the Abbott ARP as in effect as of the
     Distribution Date, with employment by the Abbott Group prior to the
     Distribution Date treated as employment by the Hospira Group under the
     Hospira ARP for purposes of determining eligibility for optional forms of
     benefit, early retirement benefits, or other benefit forms;

                       (iv)   to the extent required by Section 411(d)(6) of the
     Code, any accrued benefit, early retirement benefit, retirement-type
     subsidy, or optional form of benefit provided under the Abbott ARP during
     the Transition Period shall be provided by the Hospira ARP with respect to
     each U.S. Transferred Employee's accrued benefit as of the Distribution
     Date and service with the Abbott Group (prior to the Distribution Date) and
     the Hospira Group during the Transition Period shall be recognized for
     purposes of determining eligibility to elect or to receive those benefits;

                       (v)    all beneficiary designations in effect under the
     Abbott ARP as of the Distribution Date shall remain in effect after the
     Distribution Date under the Hospira ARP as if made under the Hospira

                                       17
<Page>

     ARP unless those designations are subsequently changed in accordance with
     the Hospira ARP; and

                       (vi)   the Hospira ARP shall assume and honor the terms
     of all QDROs in effect under the Abbott ARP as of the Distribution Date
     with respect to U.S. Transferred Employees.

                (f) COMPOSITION OF ASSETS. The composition of the assets that
will be transferred from the Abbott ARP to the Hospira ARP shall be mutually
determined by the applicable fiduciaries of the Abbott ARP and Hospira ARP.

                (g) DETERMINATION LETTER REQUESTS. Hospira shall submit an
application to the Internal Revenue Service as soon as practicable after the
Distribution Date (but no later than the last day of the remedial amendment
period as defined in applicable Code provisions) for a determination letter
regarding the qualification of the Hospira ARP and the tax status of its related
trust as of the Distribution Date and shall make any amendments reasonably
requested by the Internal Revenue Service in order to receive a favorable
determination letter regarding the Hospira ARP.

                (h) ABBOTT ARP AFTER DISTRIBUTION DATE. On and after the
Distribution Date, no employees of the Hospira Group, including U.S. Transferred
Employees, shall accrue any benefits under the Abbott ARP and their service with
and compensation from the Hospira Group on or after that date shall be
disregarded for all purposes of the Abbott ARP. Without limiting the generality
of the foregoing, each U.S. Transferred Employee shall cease to be an active
participant in the Abbott ARP effective as of the Distribution Date.

          4.2   STOCK RETIREMENT PLAN.

                (a) ESTABLISHMENT OF HOSPIRA SRP. Effective on or before the
Distribution Date, Hospira shall establish the Hospira SRP. During the
Transition Period, the terms of the Hospira SRP shall be substantially similar
in all material respects to the terms of the Abbott SRP as of the Distribution
Date; provided, however, that (i) the Hospira SRP shall not be required to be an
ESOP or to contain an ESOP feature and (ii) the Hospira SRP shall not be
required to make available an Abbott stock fund as an investment feature for
contributions made under the Hospira SRP after the Distribution Date. On or
prior to the Distribution Date, Hospira shall provide Abbott with (A) a copy of
the Hospira SRP; (B) a copy of certified resolutions of Hospira's board of
directors (or its authorized committee or other delegate) evidencing adoption of
the Hospira SRP and the related trust(s) and the assumption by the Hospira SRP
of the Liabilities set forth in Section 4.2(c) hereof; and (C) either (I) a
favorable determination letter issued by the Internal Revenue Service with
respect to the Hospira SRP and its related trust or (II) an opinion of Hospira's
counsel, which opinion is reasonably satisfactory to Abbott's counsel, with
respect to the qualified status of the Hospira SRP under Section 401(a) of the
Code and the tax-exempt status of its related trust under Section 501(a) of the
Code. As soon as practicable on or following the Distribution Date Abbott shall
cause the

                                       18
<Page>

trustee of the Abbott SRP to transfer from the trust(s) which forms a
part of the Abbott SRP to the trust(s) which forms a part of the Hospira SRP the
amounts described below.

                (b) TRANSFER OF ACCOUNT BALANCES. The amount to be transferred
(in cash, Abbott common shares, shares of Hospira common stock, promissory notes
evidencing outstanding loans to U.S. Transferred Employees and other assets or
any combination thereof in cash or in kind, as instructed by the trustees of the
Abbott SRP) from the Abbott SRP to the Hospira SRP shall equal the account
balances of U.S. Transferred Employees (excluding account balances in respect of
QDROs established in relation to U.S. Transferred Employees) under the Abbott
SRP, determined as of the date of the transfer. Hospira shall cause the
transferred amounts to be allocated among the U.S. Transferred Employees'
accounts under the Hospira SRP and to such investment funds in the same manner
in which those amounts were allocated under the Abbott SRP. Any asset and
liability transfer pursuant to this Section 4.2 shall comply in all respects
with Sections 414(l) and 411(d)(6) of the Code.

                (c) ASSUMED SRP LIABILITIES. As of the date of transfer of the
assets described in Section 4.2(b) above, Hospira shall cause the Hospira SRP to
assume all Liabilities for all accrued benefits under the Abbott SRP for the
U.S. Transferred Employees (excluding Liabilities in respect of QDROs
established in relation to U.S. Transferred Employees), and the Abbott SRP shall
be relieved of all Liabilities for those benefits.

                (d) HOSPIRA SRP DURING THE TRANSITION PERIOD.  During the
Transition Period (and thereafter to the extent required by applicable law), the
Hospira SRP shall provide that:

                       (i)    U.S. Transferred Employees shall (A) be eligible
     to participate in the Hospira SRP to the extent they were eligible to
     participate in the Abbott SRP as of the Distribution Date, and (B) receive
     credit for vesting purposes for all service credited for that purpose under
     the Abbott SRP as of the Distribution Date as if that service had been
     rendered to Hospira;

                       (ii)   the accrued benefit of each U.S. Transferred
     Employee under the Abbott SRP as of the date of the transfer of assets from
     the Abbott SRP (which accrued benefit shall be the U.S. Transferred
     Employee's account balance, including any outstanding promissory notes)
     shall be paid under the Hospira SRP at the time and in a form that would
     have been permitted under the Abbott SRP as of the Distribution Date; and

                       (iii)  all elections and beneficiary designations in
     effect under the Abbott SRP as of the Distribution Date shall remain in
     effect after the Distribution Date under the Hospira SRP as if made under
     the Hospira SRP unless those elections or designations are subsequently
     changed in accordance with the Hospira SRP.

                                       19
<Page>

                (e) DETERMINATION LETTER REQUESTS. Hospira shall submit
applications to the Internal Revenue Service as soon as practicable following
the Distribution Date (but no later than the last day of the remedial amendment
period as defined in applicable Code provisions) for a determination regarding
the qualification of the Hospira SRP and the tax status of its related trust as
of the Distribution Date and shall make any amendments reasonably requested by
the Internal Revenue Service in order to receive a favorable determination
letter regarding the Hospira SRP.

                (f) ABBOTT SRP AFTER DISTRIBUTION DATE. On and after the
Distribution Date, no employees of the Hospira Group, including U.S. Transferred
Employees, shall accrue any benefits under the Abbott SRP. Without limiting the
generality of the foregoing, U.S. Transferred Employees shall cease to be active
participants in the Abbott SRP effective as of the Distribution Date.

                (g) SRP FIDUCIARIES. For avoidance of doubt, for all periods
after the Distribution Date, the parties agree that the applicable fiduciaries
of each of the Abbott SRP and the Hospira SRP, respectively, shall have the sole
authority with respect to the Abbott SRP and the Hospira SRP, respectively, to
determine the investment alternatives, the terms and conditions with respect to
those investment alternatives and such other matters as are within the scope of
their duties under Section 404 of ERISA.

                (h) LOSS OF UNVESTED BENEFITS/DISTRIBUTIONS. For the avoidance
of doubt, the transfer of any Transferred Employee's employment to the Hospira
Group will not result in loss of that Transferred Employee's unvested benefits
under the Abbott SRP or the Hospira SRP and no Transferred Employee shall be
entitled to a distribution of his benefit under the Abbott SRP as a result of
such transfer of employment.

                (i) ABBOTT SRP QDROS.  The Abbott SRP shall retain and honor the
terms of all QDROs in effect under the Abbott SRP as of the Distribution Date
with respect to U.S. Transferred Employees.

          4.3   FAULTLESS RUBBER PLAN.

          Effective as of the Distribution Date, Hospira shall assume
sponsorship of and all of Abbott's rights, powers, duties, obligations and
Liabilities under and with respect to the Faultless Rubber Plan.

          4.4   ASHLAND 401(k) PLAN.

          Effective as of the Distribution Date, Hospira shall assume
sponsorship of any and all of Abbott's rights, powers, duties, obligations and
Liabilities under and with respect to the Ashland 401(k) Plan.

                                       20
<Page>

          4.5   SUPPLEMENTAL PENSION PLAN.

                (a) ESTABLISHMENT OF HOSPIRA SUPPLEMENTAL ARP. Effective on or
before the Distribution Date, Hospira shall establish the Hospira Supplemental
ARP which, for the Transition Period, shall be substantially similar in all
material respects to the Abbott Supplemental ARP as of the Distribution Date;
provided, however, that Hospira shall not be required to establish any grantor
or other trusts to fund benefits under the Hospira Supplemental ARP.

                (b) ASSUMED SUPPLEMENTAL ARP LIABILITIES. Except as provided
below, as of the Distribution Date, Hospira shall, and shall cause the Hospira
Supplemental ARP to, assume all Liabilities for all accrued obligations under
the Abbott Supplemental ARP for the benefits for U.S. Transferred Employees
determined as of the Distribution Date, and Abbott and the Abbott Supplemental
ARP shall be relieved of all Liabilities for those benefits. Notwithstanding the
foregoing, the parties acknowledge that certain Liabilities of Hospira with
respect to the Hospira Supplemental ARP shall be satisfied by Abbott, as
described in Section 7.4 of this Agreement.

                (c) HOSPIRA SUPPLEMENTAL ARP DURING THE TRANSITION PERIOD.  As
of the Distribution Date, the Hospira Supplemental ARP shall provide that:

                       (i)    U.S. Transferred Employees who are participants in
     the Hospira Supplemental ARP and whose benefits are transferred to the
     Hospira Supplemental ARP from the Abbott Supplemental ARP shall receive
     credit for vesting, eligibility and benefit service for all service
     credited for those purposes under the Abbott Supplemental ARP as of the
     Distribution Date as if that service had been rendered to Hospira;

                       (ii)   the compensation paid by the Abbott Group to all
     U.S. Transferred Employees which was recognized under the Abbott
     Supplemental ARP as of the Distribution Date shall be credited and
     recognized for all applicable purposes under the Hospira Supplemental ARP
     as though it were compensation from the Hospira Group; and

                       (iii)  the Hospira Supplemental ARP shall not be amended
     in any manner that would reduce the accrued benefit (including any early
     retirement subsidy) of any U.S. Transferred Employee.

                (d) ABBOTT SUPPLEMENTAL ARP AFTER DISTRIBUTION DATE. On and
after the Distribution Date, no employees of the Hospira Group, including U.S.
Transferred Employees, shall participate in or accrue any benefits under the
Abbott Supplemental ARP. Without limiting the generality of the foregoing, U.S.
Transferred Employees shall cease to participate in the Abbott Supplemental ARP
effective as of the Distribution Date.

                                       21
<Page>

          4.6   ABBOTT SUPPLEMENTAL 401(k) PLAN.

                (a) ESTABLISHMENT OF HOSPIRA KSP. Effective on or before the
Distribution Date, Hospira shall establish the Hospira KSP which, for the
Transition Period, shall be substantially similar in all material respects to
the Abbott KSP as of the Distribution Date; provided, however, that (i) Hospira
may limit participation in the Hospira KSP to KSP Transferred Employees and (ii)
Hospira shall not be required to establish any grantor or other trusts to fund
benefits under the Hospira KSP.

                (b) ABBOTT KSP LIABILITIES. Except as expressly provided in
Section 4.6(c) of this Agreement, Abbott shall retain all Liabilities relating
to, arising out of, or resulting from the Abbott KSP. As of the Distribution
Date, Abbott shall take all action reasonably necessary to convert the Deferred
Account (as defined in the Abbott KSP) of any KSP Transferred Employee into a
Trust Account (as defined in the Abbott KSP). Except as expressly provided in
Section 4.6(c) of this Agreement, on and after the Distribution Date, no
employees of the Hospira Group, including KSP Transferred Employees, shall
participate in or accrue any benefits under the Abbott KSP.

                (c) HOSPIRA KSP BOOK ACCOUNTS. During the Transition Period,
Hospira shall maintain an unfunded book account under the Hospira KSP for KSP
Transferred Employees. Hospira shall credit those accounts with (i) the amounts
deferred by KSP Transferred Employees into the Hospira KSP according to
elections made by those KSP Transferred Employees plus (ii) any related employer
matching contributions in relation to the amounts described in (i). In the
absence of a new election made by KSP Transferred Employees under the Hospira
KSP, Hospira shall honor the terms of elections made by KSP Transferred
Employees under the Abbott KSP. As soon as practicable following the Transition
Period, Hospira shall pay Abbott (or the trustee of the applicable KSP
Transferred Employee's grantor trust) an amount equal to the aggregate balance
of the book accounts described above and Abbott shall ensure that those amounts
are allocated accordingly among the grantor trusts of those KSP Transferred
Employees. Abbott shall maintain the grantor trusts in accordance with Section
7.4 of this Agreement.

                                    ARTICLE 5

                            NON-U.S. RETIREMENT PLANS

          5.1   CANADIAN PENSION PLAN.

          Effective on or before the Distribution Date, Hospira shall establish
the Hospira Canadian Pension Plan the terms of which shall be substantially
similar in all material respects to the terms of the Abbott Laboratories,
Limited Retirement Income Plan as in effect immediately prior to the
Distribution Date. For two (2) years following the Distribution Date, Hospira
shall not materially amend the Hospira Canadian Pension Plan other than as
required by applicable law. The assets and Liabilities determined as of the
Distribution Date under the Abbott Laboratories, Limited Retirement Income Plan
attributable to Non-U.S. Transferred Employees who are participants in that plan
shall be

                                       22
<Page>

transferred to the Hospira Canadian Pension Plan. The amount of assets and
Liabilities subject to the transfer shall be calculated on a Projected Benefit
Obligation basis, as determined under FAS 87, by Mercer Human Resource
Consulting LLC, and the amount of the transfer and the terms and conditions of
the transfer shall be approved by Abbott's Vice President, Compensation and
Development and Hospira's Vice President of Compensation & Benefits. Abbott and
Hospira agree to use commercially reasonable efforts to accomplish this transfer
as soon as practicable following the Distribution Date and to cooperate with
each other to make such filings and disclosures and obtain such approvals as may
be deemed necessary or advisable.

          5.2   IRISH PENSION PLANS.

          The assets and Liabilities determined as of the Distribution Date
under the Abbott Ireland Pension & Death Benefit Plan for Salaried Staff, Abbott
Ireland Pension & Death Benefit Plan for Executive Staff, and Abbott Ireland
Pension & Death Benefit Plan for Hourly Employees attributable to Non-U.S.
Transferred Employees who are participants in those plans shall be transferred
to defined benefit pension plans to be established by Hospira. The amount of
assets and Liabilities subject to the transfer shall be calculated on an
Accumulated Benefit Obligation basis, as determined under FAS 87, by the
trustees of those plans, in consultation with Mercer Human Resources Consulting
LTD, and the amount of the transfer and the terms and conditions of the transfer
shall be approved by Abbott's Vice President, Compensation and Development and
Hospira's Vice President of Compensation & Benefits. Abbott and Hospira agree to
use commercially reasonable efforts to accomplish these transfers as soon as
practicable following the Distribution Date and to cooperate with each other to
make such filings and disclosures and obtain such approvals as may be deemed
necessary or advisable.

          5.3   OVERSEAS MANAGERS' PENSION PLAN.

                (a) ESTABLISHMENT OF HOSPIRA OMPP. Effective on or before the
Distribution Date, Hospira shall establish the Hospira OMPP which shall be
substantially similar in all material respects to the Abbott OMPP as of the
Distribution Date provided, however, that Hospira may limit participation in the
Hospira OMPP to Transferred Employees who participated in the Abbott OMPP
immediately prior to their Transfer Dates. Except as provided below, Hospira may
amend the Hospira OMPP at any time following the Distribution Date, including
during the Transition Period.

                (b) ASSUMED OMPP LIABILITIES. As of the Distribution Date,
Hospira shall, and shall cause the Hospira OMPP to assume all Liabilities for
all accrued obligations under the Abbott OMPP for the benefits for Non-U.S.
Transferred Employees determined as of the Distribution Date, and Abbott and the
Abbott OMPP shall be relieved of all Liabilities for those benefits.

                (c) HOSPIRA OMPP AS OF DISTRIBUTION DATE.  As of the
Distribution Date, the Hospira OMPP shall provide that:

                                       23
<Page>

                       (i)    Non-U.S. Transferred Employees who are
     participants in the Hospira OMPP and whose benefits are transferred to the
     Hospira OMPP from the Abbott OMPP shall receive credit for vesting,
     eligibility and benefit service for all service credited for those purposes
     under the Abbott OMPP as of the Distribution Date as if that service had
     been rendered to Hospira;

                       (ii)   the compensation paid by the Abbott Group to all
     Non-U.S. Transferred Employees which was recognized under the Abbott OMPP
     as of the Distribution Date shall be credited and recognized for all
     applicable purposes under the Hospira OMPP as though it were compensation
     from the Hospira Group; and

                       (iii)  the Hospira OMPP shall not be amended in any
     manner that would reduce the accrued benefit (including any early
     retirement subsidy) of any Non-U.S. Transferred Employee.

                (d) ABBOTT OMPP AFTER DISTRIBUTION DATE. On and after the
Distribution Date, no employees of Hospira, including Non-U.S. Transferred
Employees, shall participate in or accrue any benefits under the Abbott OMPP.
Without limiting the generality of the foregoing, Non-U.S. Transferred Employees
shall cease to participate in the Abbott OMPP effective as of the Distribution
Date.

          5.4   OTHER NON-U.S. RETIREMENT PLANS. If Hospira assumes any
Liabilities with respect to Non-U.S. Transferred Employees under an Abbott
Benefit Plan which is a defined benefit pension plan, and such Liabilities are
not otherwise addressed in this Article 5, then Abbott's Vice President,
Compensation and Development and Hospira's Vice President of Compensation and
Benefits shall mutually agree as to the amount, if any, of the assets to be
transferred by the Abbott Group (or the relevant Abbott Benefit Plan) to the
Hospira Group (or the relevant Hospira Benefit Plan) with respect to such
Liabilities.

                                    ARTICLE 6

                        WELFARE AND FRINGE BENEFIT PLANS

          6.1   SEVERANCE COMPENSATION AND BENEFITS.

          In accordance with Section 2.1 of this Agreement, Hospira shall be
responsible for any and all Liabilities to, or relating to, Transferred
Employees relating to severance and unemployment compensation and benefits and,
except as expressly provided below, Abbott shall be responsible for any and all
Liabilities to, or relating to, Abbott Retained Employees relating to severance
and unemployment compensation and benefits. Notwithstanding the foregoing, in
the event that, with respect to any country, (a) the number of Post-Distribution
Transferred Employees in that country at the conclusion of Abbott's provision of
transitional services in that country is less than the

                                       24
<Page>

Allocated Employee Number for that country and (b) Abbott reasonably concludes
that it must layoff Post-Distribution Employees in that country as a result of
the Hospira Group's failure to employ a number of Post-Distribution Employees in
that country equal to the Allocated Employee Number, then, subject to the
following sentence, Hospira shall reimburse Abbott for the costs associated with
those layoffs. Notwithstanding the foregoing, Hospira shall not be required to
reimburse Abbott for a number of layoffs in any country greater than (i) the
Allocated Employee Number for that country less (ii) the sum of (x) the number
of Post-Distribution Transferred Employees in that country and (y) the number of
Post-Distribution Employees in that country (other than Post-Distribution
Transferred Employees) to whom Hospira makes an offer of employment that
includes cash and long-term incentive compensation equivalent to that provided
to the Post-Distribution Employee by the Abbott Group.

          6.2   RETIREE MEDICAL AND LIFE INSURANCE COVERAGE.

                (a) ABBOTT HEALTHCARE AND LIFE INSURANCE COVERAGE. Abbott shall
extend post-retirement healthcare and life insurance coverage under the Abbott
Retiree Medical Plan and the Abbott Retiree Life Plan to each U.S. Transferred
Employee (including any of his or her eligible dependents) who, as of the
Distribution Date, is eligible to retire under the Abbott ARP. Any U.S.
Transferred Employee who is eligible to elect coverage (or any eligible
dependent who is eligible to elect coverage) under the Abbott Retiree Medical
Plan and Abbott Retiree Life Plan shall be entitled to elect to begin that
coverage as of any date elected by that U.S. Transferred Employee that is after
the Distribution Date and on or after his or her termination of employment (for
any reason) with the Hospira Group. Any post-retirement healthcare and life
insurance coverage provided to U.S. Transferred Employees (and his or her
dependents) shall be subject in all respects to the terms and conditions of the
Abbott Retiree Medical Plan and Abbott Retiree Life Plan as in effect from time
to time. Abbott shall be solely liable for any such post-retirement healthcare
and life insurance coverage.

                (b) ABBOTT COVERAGE REQUIREMENTS. Abbott expressly reserves the
right to amend, alter, modify or terminate the terms of the Abbott Retiree
Medical Plan and/or the Abbott Retiree Life Plan, as the case may be, at any
time and to interpret the provisions of those plans with respect to its
employees, U.S. Transferred Employees and all of its other former employees and
their respective dependents; provided, however, that Abbott agrees that any
amendments, alterations, modifications, or terminations with respect to those
plans shall be applied in a consistent manner to Abbott retirees and U.S.
Transferred Employees who are eligible for coverage under those plans. Abbott
shall not be responsible or otherwise liable for the provision of
post-retirement healthcare and life insurance coverage to any U.S. Transferred
Employees other than as expressly provided in this Section 6.2. Only service and
compensation with the Abbott Group prior to the Distribution Date shall be taken
into account for all purposes of the Abbott Retiree Health Plan and the Abbott
Retiree Life Plan, including, but not limited to, for purposes of determining
contribution levels.

                (c) HOSPIRA HEALTHCARE AND LIFE INSURANCE COVERAGE. Nothing in
this Agreement shall require Hospira to establish or maintain any
post-termination

                                       25
<Page>

healthcare and life insurance coverage for any person, except as required by
COBRA or other applicable law.

          6.3   VEBAs.

          Effective as of the Distribution Date, Hospira shall establish the
Hospira VEBA and shall take all actions reasonably necessary to ensure that the
Hospira VEBA satisfies the requirements of Section 501(c)(9) of the Code and is
exempt from tax under Section 501(a) of the Code, including, but not limited to,
filing any required determination letter filing with the Internal Revenue
Service. Effective as of the Distribution Date, after making appropriate
adjustment for any incurred but not reported claims payable from the Abbott
VEBAs, Abbott shall cause each of the Abbott VEBAs to transfer to the Hospira
VEBA any remaining assets and reserves under the Abbott VEBAs which are
attributable to contributions by U.S. Transferred Employees. Abbott and Hospira
shall each take any and all actions as they deem necessary or appropriate to
ensure that the transfer of assets and reserves from the Abbott VEBAs to the
Hospira VEBA does not result in any adverse tax consequences to any of the
Abbott VEBAs or the Hospira VEBA, Abbott, Hospira, or any participants or
beneficiaries under the Abbott VEBAs or the Hospira VEBA. Abbott and Hospira
shall cooperate with each other to effect the provisions of this Section 6.3.

          6.4   COBRA.

          Effective as of the Distribution Date, Hospira shall assume all
obligations for providing COBRA coverage to U.S. Transferred Employees (and
their eligible dependents), regardless of whether the qualifying event giving
rise to that coverage occurred prior to, on, or after the Distribution Date.

          6.5   MATCHING GRANT AND COMBINED APPEAL PROGRAMS.

                (a) MATCHING GRANT PROGRAM. Abbott shall retain all Liabilities
with respect to the Abbott Laboratories Matching Grant Program. Abbott shall
match all eligible contributions and grants made by each U.S. Transferred
Employee prior to the Distribution Date, in accordance with the terms of the
Abbott Laboratories Matching Grant Program. Hospira shall not be required to
maintain a matching contribution program following the Distribution Date.

                (b) COMBINED APPEAL PROGRAM. Hospira shall establish a Combined
Appeal Program with terms that are substantially similar to the terms of
Abbott's Combined Appeal Program as of the Distribution Date. Absent a new
election by a U.S. Transferred Employee under Hospira's Combined Appeal Program,
Hospira shall honor elections made by U.S. Transferred Employees pursuant to
Abbott's Combined Appeal Program. Hospira shall not be required to maintain a
Combined Appeal Program following the Transition Period.

                                       26
<Page>

                                    ARTICLE 7

                   EQUITY AND EXECUTIVE COMPENSATION PROGRAMS

          7.1   EQUITY INCENTIVE PROGRAMS.

                (a) TREATMENT OF ABBOTT OPTIONS/NON-RETIREMENT ELIGIBLE. Subject
to Sections 7.1(c) and (d) of this Agreement, as of the Distribution Date, (i)
Abbott shall cancel, as of the Distribution Date, each Abbott Option held by a
Transferred Employee who is not eligible to retire under the Abbott ARP or any
other Abbott retirement plan designated by Abbott as of the Distribution Date
(where that retirement eligibility shall be determined by Abbott in its sole
discretion as of the Distribution Date, based on the terms and conditions of the
Abbott ARP or such other retirement plan covering the applicable Transferred
Employee, as applicable) and which is outstanding immediately prior to the
Distribution Date (whether or not then exercisable), and (ii) Hospira shall
grant each such Transferred Employee a Hospira Option in respect of such
cancelled Abbott Option.

          The number of covered shares and the exercise price of the Hospira
Options shall reflect the Distribution and preserve the corresponding Abbott
Option's intrinsic value as of the Distribution Date, that value being equal to
(A) the difference between the fair market value of a share of Abbott common
stock at the last closing price prior to the Distribution less that Abbott
Option's exercise price per share, multiplied by (B) the number of shares
subject to that Abbott Option. Each Hospira Option shall maintain the same ratio
between the exercise price per share and the fair market value per share as
reflected in the respective Abbott Option being cancelled. The exercise price
and number of shares subject to a Hospira Option granted in respect of the
cancelled Abbott Option shall be determined in accordance with Section 424 of
the Code so as to retain, where applicable and possible, the tax and accounting
treatment of each such Abbott Option.

          The Hospira Options shall contain substantially similar terms and
conditions as the Abbott Options for which they were substituted. On or prior to
the Distribution Date, Abbott and Hospira shall take such actions necessary to
effectuate the foregoing, including compliance with securities laws and other
legal requirements associated with the grant of stock options in the affected
non-U.S. jurisdictions. Abbott agrees to assist and facilitate the adoption and
approval of the Hospira SIP in order to maximize the possible tax benefits to
Hospira consistent with the requirements of Treasury Regulation Section
1.162-27(f)(4)(iii).

                (b) TREATMENT OF ABBOTT OPTIONS/RETIREMENT ELIGIBLE. With
respect to each Abbott Option which is held by a Transferred Employee eligible
to retire under the Abbott ARP or another Abbott retirement plan as of the
Distribution Date (where that retirement eligibility shall be determined by
Abbott in its sole discretion as of the Distribution Date, based on the terms
and conditions of the ARP or such other retirement plan covering the applicable
Transferred Employee, as applicable) and which is outstanding immediately prior
to the Distribution Date (whether or not then

                                       27
<Page>

exercisable), the Abbott Compensation Committee shall take the necessary actions
on or prior to the Distribution Date to provide, solely for purposes of the
Abbott Stock Programs, that a retirement eligible Transferred Employee's
separation from employment with Abbott to be employed with Hospira, under the
provisions of this Agreement, shall be treated as a retirement from an Abbott
retirement plan for purposes of the Abbott Stock Programs. The Abbott
Compensation Committee shall make adjustments to Options held by a retirement
eligible Transferred Employee in accordance with the terms of the Abbott Stock
Programs as it deems necessary and/or appropriate to reflect the spin-off of the
Hospira Business.

                (c) ABBOTT OPTIONS IN CERTAIN NON-U.S. JURISDICTIONS.
Notwithstanding the provisions of Section 7.1(a) of this Agreement, Abbott and
Hospira may mutually agree, in their sole discretion, not to cancel an Abbott
Option and grant a corresponding Hospira Option in non-U.S. jurisdictions where
those actions will create or trigger adverse legal, accounting or tax
consequences for either Abbott, Hospira, and/or the affected Non-U.S.
Transferred Employees. In such circumstances, the Abbott Options of the affected
Non-U.S. Transferred Employees shall terminate in accordance with the terms of
the Abbott Stock Programs and the underlying option agreement and Hospira shall
equitably compensate the affected Non-U.S. Transferred Employees in an alternate
manner determined by Hospira in its sole discretion.

                (d) TREATMENT OF ABBOTT OPTIONS/POST-DISTRIBUTION TRANSFERRED
EMPLOYEES. Notwithstanding the provisions of Section 7.1(a) of this Agreement,
each Abbott Option held by a Post-Distribution Transferred Employee or a Hospira
Requested Employee who is not eligible to retire under the Abbott ARP or any
other Abbott retirement plan designated by Abbott as of his or her Transfer Date
(where that retirement eligibility shall be determined by Abbott in its sole
discretion as of that Transfer Date, based on the terms and conditions of the
ARP or such other retirement plan covering that Employee, as applicable) and
which is outstanding immediately prior to that Transfer Date shall terminate in
accordance with the terms of the Abbott Stock Programs and the underlying option
agreement and Hospira shall equitably compensate that Employee in an alternate
manner determined by Hospira in its sole discretion.

                (e) RESTRICTED STOCK. The Abbott Compensation Committee shall
take the necessary actions on or prior to the Distribution Date to cause the
lapse of Restrictions (as defined in the applicable award agreements) with
respect to all Abbott restricted stock granted under the Abbott Stock Programs
held by each Transferred Employee (retirement eligible and non-retirement
eligible) as of the Distribution Date.

          7.2   DISCONTINUED PARTICIPATION IN ESPP.

          As of the Distribution Date, each Non-U.S. Transferred Employee (other
than a Post-Distribution Transferred Employee or Hospira Requested Employee) who
participates in the Abbott ESPP shall cease participation in the Abbott ESPP and
shall have his or her payroll deductions refunded by the Abbott Group as soon as
administratively practicable in accordance with the terms of the Abbott ESPP. As
of the Transfer Date, each Post-Distribution Transferred Employee or Hospira
Requested

                                       28
<Page>

Employee who participates in the Abbott ESPP shall cease participation
in the Abbott ESPP and shall have his or her payroll deductions refunded by the
Abbott Group as soon as administratively practicable in accordance with the
terms of the Abbott ESPP.

          7.3   DEFERRED COMPENSATION PLAN.

          Abbott shall retain all Liabilities relating to, arising out of, or
resulting from the Abbott DCP. Prior to ______, 2004 (or such later date as
Abbott may determine, but in no event later than the Distribution Date), Abbott
shall amend the Abbott DCP to provide that each Employee shall make an election,
prior to ______, 2004 (or such later date as Abbott may determine, but in no
event later than the Distribution Date) to either (i) treat that Employee's
commencement of employment with the Hospira Group as a 'termination of
employment' (as defined in the Abbott DCP) with Abbott, provided that that
Employee remains an employee of the Abbott Group through the date immediately
prior to the Distribution Date or (ii) treat that Employee's continuation of
employment with the Hospira Group as if it was a continuation of employment with
the Abbott Group solely for purposes of distribution of benefits (and not
continued contributions). Those U.S. Transferred Employees who participate in
the Abbott DCP and who do not timely execute an election shall be treated as
having made an election pursuant to (ii) above. In the event that a Transferred
Employee makes an election pursuant to (i) above, distributions from the Abbott
DCP shall not begin any sooner than one (1) year following that Transferred
Employee's Transfer Date. Hospira agrees that it shall provide written notice to
Abbott of the subsequent termination of employment of a Transferred Employee who
makes an election pursuant to (ii) above, in order for Abbott to carry out its
obligations hereunder. With respect to any Transferred Employee who makes an
election pursuant to (ii) above, subsequent termination of employment from the
Hospira Group shall have the same effect under the Abbott DCP as a termination
of employment from the Abbott Group. No deferrals shall be made under the Abbott
DCP in respect of Transferred Employees with respect of any period following the
Distribution Date.

          7.4   GRANTOR TRUSTS.

                (a) GRANTOR TRUST PAYMENT ELECTION. On or prior to the
Distribution Date, Abbott shall solicit from each U.S. Transferred Employee, who
has a grantor trust that was created pursuant to an Abbott Benefit Plan, a newly
completed Grantor Trust Payment Election form for each such trust. The new forms
shall acknowledge that continued employment with the Hospira Group shall have
the same effect as continued employment with the Abbott Group with respect to
the determination of the settlement date under those trusts. Hospira agrees that
it shall provide written notice to Abbott of the subsequent termination of
employment of a U.S. Transferred Employee with a grantor trust subject to this
Section 7.4, in order for Abbott to carry out its obligations hereunder and
under the grantor trust. Abbott agrees that it shall, as administrator of the
applicable trusts, inform the trustee of the grantor trusts of the proper
settlement dates, when they occur, based on those U.S. Transferred Employees'
continued employment with, and subsequent termination from, Hospira. A
subsequent termination

                                       29
<Page>

of employment from the Hospira Group shall have the same effect under the terms
of the grantor trusts as a termination of employment from the Abbott Group.

                (b) MAINTENANCE OF GRANTOR TRUSTS. Abbott will retain the
Liabilities associated with the Abbott Supplemental ARP for U.S. Transferred
Employees who have grantor trusts. Abbott shall continue to be obligated to
maintain all U.S. Transferred Employee's grantor trusts which were created
pursuant to any Abbott Benefit Plan and shall continue to make annual
contributions as may be required pursuant to the terms and conditions of those
grantor trusts. Abbott shall treat any contributions relating to services
provided during the Transition Period that are made into the applicable grantor
trusts (either by Abbott or Hospira) the same as contributions relating to
services provided prior to the Distribution Date which were made into the trusts
by Abbott.

                (c) NECESSARY ACTIONS. Abbott shall take all commercially
reasonable actions deemed necessary to give effect to this Section 7.4,
including, but not limited to, amending the grantor trusts or any related Abbott
Benefit Plan.

                (d) HOSPIRA CONTRIBUTIONS. Hospira shall be obligated to make
contributions to the applicable grantor trusts with respect to any amounts
earned for services rendered to the Hospira Group during the Transition Period,
whether those amounts are paid directly to the trustee for the applicable
grantor trusts or to Abbott for contributions into the applicable grantor
trusts, at the same time and in the same manner, as contributions are made by
Abbott with respect to any amounts earned for services rendered to Abbott prior
to the Distribution Date.

          7.5   CASH PROFIT SHARING.

          Each U.S. Transferred Employee who participated in the Abbott Cash
Profit Sharing Plan immediately prior to the Distribution Date and who remains
employed by the Hospira Group after the Distribution Date and through November
15, 2004, shall be entitled to receive from Hospira a cash payment for the 2004
plan year ending September 30, 2004 based on the same percentage of eligible
earnings used under the Abbott Cash Profit Sharing Plan for such plan year. The
terms and conditions of payments to be made by Hospira pursuant to this Section
7.5 shall be substantially similar in all material respects to those that
applied under the Abbott Cash Profit Sharing Plan as in effect on the
Distribution Date. Hospira shall make all determinations of payments under this
Section 7.5 and shall be solely responsible for all payments to or with respect
to U.S. Transferred Employees hereunder. Hospira shall have no obligation to
provide any cash profit sharing plan in respect of periods following September
30, 2004.

          7.6   OTHER INCENTIVE PROGRAMS.

          During the Transition Period, Hospira shall provide U.S. Transferred
Employees with Hospira cash incentive programs (other than the Abbott Cash
Profit Sharing Plan, the treatment of which is addressed in Section 7.5 above)
on terms and conditions which are substantially similar in all material respects
to the terms and conditions of the cash incentive programs provided to those
U.S. Transferred Employees

                                       30
<Page>

on the Distribution Date; provided, however that, after the Distribution Date,
Hospira may change the performance metrics and criteria to reflect its incentive
strategies. All payments to U.S. Transferred Employees under the cash incentive
programs described in this Section 7.6 shall be made at such times as prescribed
by those programs. Hospira shall make in its sole discretion all determinations
of payments under the cash incentive programs described in this Section 7.6 with
respect to U.S. Transferred Employees and shall be solely responsible for all
payments to or with respect to U.S. Transferred Employees hereunder. Hospira
shall have no obligation to continue any cash incentive program following the
Transition Period.

                                    ARTICLE 8

                                  MISCELLANEOUS

          8.1   TRANSFER OF RECORDS AND INFORMATION.

          Subject to applicable law, Abbott shall transfer to Hospira any and
all employment records and information (including, but not limited to, any Form
W-2 or other Internal Revenue Service forms) with respect to Transferred
Employees and other records reasonably required by Hospira to enable Hospira to
properly carry out its obligations under this Agreement. Such transfer of
records and information shall generally occur as soon as administratively
practicable following (a) the date hereof or (b) with respect to records and
information that are relevant to services provided in the Transition Services
Agreements, the date upon which the provision of those services terminates.
After the transfer of those records to Hospira, Hospira shall permit Abbott to
have reasonable access to such records and such information, each as set forth
in Article VI of the Separation and Distribution Agreement.

          8.2   PRESERVATION OF RIGHTS TO AMEND OR TERMINATE PLANS.

          Nothing in this Agreement shall be construed as a limitation on the
right of the Abbott Group or the Hospira Group to amend or terminate any Benefit
Plan so long as that amendment or termination is not contrary to this Agreement.
In addition, nothing in this Agreement shall be construed as a limitation on the
right of the Abbott Group or the Hospira Group to amend any Benefit Plan to
conform to requirements of applicable law or the provisions of a collective
bargaining agreement, including any changes that are effective during the
Transition Period.

                                       31
<Page>

          8.3   TRANSITION SERVICES.

          Except as otherwise provided in the Transition Services Agreements or
as otherwise expressly provided herein, neither party shall have any
responsibility for providing services to the other party with respect to
employee or Benefit Plan matters after the Distribution Date.

          8.4   REIMBURSEMENT.

          Abbott and Hospira acknowledge that the Abbott Group, on the one hand,
and the Hospira Group, on the other hand, may incur costs and expenses
(including, without limitation, contributions to Benefit Plans and the payment
of insurance premiums) which are, as set forth in this Agreement, the
responsibility of the other party. Accordingly, Abbott and Hospira agree to
reimburse each other, as soon as practicable but in any event within thirty (30)
days of receipt from the other party of appropriate verification, for all such
costs and expenses.

          8.5   CLARA ABBOTT FOUNDATION.

          For purposes of clarification, no reference to benefits or Benefit
Plan contained in this Agreement shall include or affect the benefits and
services provided to employees or retirees of the Abbott Group by the Clara
Abbott Foundation.

          8.6   INCORPORATION BY REFERENCE.

          The following sections of the Separation and Distribution Agreement
are hereby incorporated into this Agreement by reference: Section 9.01.
Counterparts; Entire Agreement; Corporate Power; Facsimile Signatures, Section
9.02. Governing Law, Section 9.04. Third Party Beneficiaries, Section 9.05.
Notices, Section 9.06. Severability, Section 9.07. Force Majeure, Section 9.08.
Responsibility for Expenses, Section 9.09. Headings, Section 9.10. Survival of
Covenants, Section 9.12. Waivers of Default, and Section 9.13. Amendments.

          8.7   LIMITATION ON ENFORCEMENT.

          This Agreement is an agreement solely between Abbott and Hospira and,
to the extent applicable, TAP. Nothing in this Agreement, whether express or
implied, confers upon any employee of the Abbott Group, the Hospira Group, TAP,
any Employee, any beneficiary of an Employee, any former employee of the Abbott
Group or TAP or any other person, any rights or remedies, including, but not
limited to any right to (a) employment or recall; (b) continued employment or
continued service for any specified period; or (c) claim any particular
compensation, benefit or aggregation of benefits, of any kind or nature.

          8.8   ASSIGNABILITY.

          This Agreement will be binding upon and inure to the benefit of the
parties hereto and their respective successors and permitted assigns; provided,
however,

                                       32
<Page>

that no party hereto may assign its respective rights or delegate its
respective obligations under this Agreement without the express prior written
consent of the other parties hereto. Notwithstanding the foregoing, this
Agreement will be assignable in whole in connection with a merger or
consolidation or the sale of all or substantially all of the Assets (as defined
in the Separation and Distribution Agreement) of a party hereto so long as the
resulting, surviving or transferee Person (as defined in the Separation and
Distribution Agreement) assumes all the obligations of the relevant party hereto
by operation of law or pursuant to an agreement in form and substance reasonably
satisfactory to the other parties hereto.

          8.9   FURTHER ASSURANCES AND CONSENTS.

          In addition to the actions specifically provided elsewhere in this
Agreement, each of the parties hereto shall use commercially reasonable efforts
to (a) execute and deliver such further instruments and documents and take such
other actions as the other party may reasonably request in order to effectuate
the purposes of this Agreement and carry out the terms hereof; (b) take or cause
to be taken, all actions and do, or cause to be done, all things, reasonably
necessary, proper or advisable under applicable laws, regulations and agreements
or otherwise to consummate and make effective the transactions contemplated by
this Agreement, including, without limitation, using commercially reasonable
efforts to obtain any consent and approvals and to make any filings and
applications necessary or desirable in order to consummate the transactions
contemplated by this Agreement; provided that no party hereto shall be obligated
to pay any consideration therefor (except for filing fees and other similar
charges) to any third party from whom those consents, approvals and amendments
are required or to take any action or omit to take any action if the taking or
the omission to take action would be unreasonably burdensome to the party or the
business thereof.

          8.10  THIRD PARTY CONSENT.

          If the obligation of any party under this Agreement is dependent on
the consent of a third party, such as a vendor or insurance company, and that
consent is withheld, Abbott and Hospira shall use commercially reasonable
efforts to implement the applicable provisions of this Agreement to the fullest
extent practicable. If any provision of this Agreement cannot be implemented due
to the failure of a third party to consent, Abbott and Hospira shall negotiate
in good faith to implement the provision in a mutually satisfactory manner,
taking into account the original purposes of the provision in light of the
Distribution and communications to affected Transferred Employees.

          8.11  EFFECT IF DISTRIBUTION DOES NOT OCCUR.

          If the Distribution does not occur, then all actions and events that
are to be taken under this Agreement as of the Distribution Date or otherwise in
connection with the Distribution, shall not be taken or occur except to the
extent specifically provided by Abbott.

                                       33
<Page>

          8.12  DISPUTES.

          Abbott and Hospira agree to use commercially reasonable efforts to
resolve in an amicable manner any and all controversies, disputes and claims
between them arising out of or related in any way to this Agreement. Abbott and
Hospira agree that any controversy, dispute or claim (whether arising in
contract, tort or otherwise) arising out of or related in any way to this
Agreement, which cannot be amicably resolved informally will be resolved
pursuant to the alternative dispute resolution procedures set forth in Article
VII of the Separation and Distribution Agreement and the Master ADR Agreement
attached hereto as Schedule 5.

          8.13  SCHEDULES.

          As of the Distribution Date, the parties shall update Schedules 2 and
4 to this Agreement.

          8.14  MUTUAL DRAFTING.

          This Agreement will be deemed to be the joint work product of the
parties and any rule of construction that a document shall be interpreted or
construed against a drafter of such document shall not be applicable.

                                       34
<Page>

          The parties have caused this Agreement to be signed by their
authorized representatives as of the Distribution Date.

HOSPIRA, INC.                                    ABBOTT LABORATORIES

BY                                               BY
  ----------------------------                     -----------------------------

TITLE                                            TITLE
     -------------------------                        --------------------------

SOLELY FOR PURPOSES OF SECTIONS 2.4, 8.7, AND 8.8

TAP PHARMACEUTICAL PRODUCTS INC.

BY
  ----------------------------

                                       35<Page>

                                                                    Exhibit 10.4

                              TAX SHARING AGREEMENT

                                     between

                               ABBOTT LABORATORIES

                               on behalf of itself

                            and the ABBOTT AFFILIATES

                                       and

                                  HOSPIRA, INC.

                               on behalf of itself

                           and the HOSPIRA AFFILIATES

<Page>

                              TAX SHARING AGREEMENT

        This Tax Sharing Agreement (the "Agreement") is entered into as of the
_________ day of _________, 2004, between Abbott Laboratories ("Abbott"), an
Illinois corporation, and Hospira, Inc. ("Hospira"), a Delaware corporation.

                                R E C I T A L S:

        WHEREAS, the board of directors of Abbott has determined that it is
appropriate and advisable to: (i) separate Abbott's core hospital business from
Abbott's remaining businesses (the "Separation"), which will include the
transfer of the assets (including interests in intangible assets and stock of
subsidiaries) used in connection with the core hospital business to Hospira (the
"Contribution"); and (ii) following the Separation, make a distribution, on a
pro rata basis, to holders of common shares, without par value, of Abbott
(together with the associated preferred stock purchase rights) of all of the
outstanding shares of common stock, par value $0.01 per share, of Hospira
(together with the associated preferred stock purchase rights), owned by Abbott
(the "Distribution") (the date of such Distribution, the "Distribution Date");
and

        WHEREAS, Abbott and Hospira intend that the Contribution and
Distribution and certain other transactions effected as part of the Separation
qualify as Tax-free under Sections 355 and 361 of the Internal Revenue Code of
1986, as amended (the "Code");

        WHEREAS, as of the date hereof, Abbott is the common parent of an
affiliated group of domestic corporations, including Hospira, that has elected
to file consolidated U.S. federal income Tax Returns and, as a result of the
Distribution, neither Hospira nor any of its Affiliates will be a member of such
group after the close of the Distribution Date;

                                      - 1 -
<Page>

        WHEREAS, Abbott and Hospira desire to allocate the responsibilities for
various Taxes and to provide for certain additional Tax matters;

        NOW, THEREFORE, in consideration of the mutual agreements, provisions
and covenants contained in this Agreement, Abbott and Hospira (each on behalf of
itself, each of its Affiliates as of the Effective Time, and its future
Affiliates) hereby agree as follows:

ARTICLE I.      DEFINITIONS

Section 1.01    Definitions. Reference is made to Section 5.13 regarding the
interpretation of certain words and phrases used in this Agreement. In addition,
for the purpose of this Agreement, the following terms shall have the meanings
set forth below.

"Abbott" has the meaning set forth in the Preamble.

"Abbott Group" means Abbott and all Affiliates of Abbott other than any member
of the Hospira Group.

"Affiliate" means any entity that is directly or indirectly under the Control of
the entity in question.

"After-Tax Amount" means, with respect to any payment under this Agreement, an
additional amount necessary to reflect the increase in Tax that would result
from the receipt or accrual of any payment, using the maximum statutory rate (or
rates, in the case of an item that affects more than one Tax) applicable to the
recipient of such payment for the relevant Tax periods, whether or not an actual
increase occurs, and reflecting any Tax savings available to the recipient.

                                      - 2 -
<Page>

"Agreement" has the meaning set forth in the Preamble.

"Bahamian Distribution" has the meaning ascribed to such term in Section
3.01(a).

"Closing Date" means, for any country, the date the TMDS Agreement for that
country terminates.

"Code" has the meaning ascribed to such term in the second WHEREAS clause
hereof.

"Contribution" has the meaning ascribed to such term in the first WHEREAS clause
hereof.

"Control" means the possession, directly or indirectly, of the power to direct
or cause the direction of the management and policies of an entity, whether
through ownership of voting securities, by contract or otherwise.

"Corresponding Portion of the Tax Detriment" means the product of the Tax
Detriment and a fraction the numerator of which is the amount of the related Tax
Benefit for a taxable period and the denominator of which is the sum of the
related Tax Benefits for all of the relevant taxable periods.

"Covered Transaction Tax" has the meaning ascribed to such term in
Section 3.01(a).

                                      - 3 -
<Page>

"Determination" means (i) with respect to U.S. federal income Tax, a
"determination" as defined in Section 1313(a) of the Code or execution of an
Internal Revenue Service Form 870AD and, with respect to a Tax other than U.S.
federal income Tax, any final determination of liability for such Tax that,
under applicable law, is not subject to further appeal, review, or modification
through proceedings or otherwise, (ii) the expiration of a statute of
limitations for making an assessment or filing a claim of refund, or (iii) the
payment of, or incurring liability for, Tax with respect to which the party
paying or incurring such Tax determines that no action should be taken to recoup
such payment or contest such liability.

"Distribution" has the meaning ascribed to such term in the first WHEREAS clause
hereof.

"Distribution Agreement" means the Separation and Distribution Agreement entered
into by and between Abbott and Hospira as the same may be amended.

"Distribution Date" has the meaning ascribed to such term in the first WHEREAS
clause hereof.

"EBA" means the Employee Benefits Agreement entered into by and between Abbott
and Hospira as the same may be amended.

"Effective Time" means 11:59 p.m. Eastern Time on the Distribution Date.

"Employment Taxes" means withholding, payroll, social security, workers
compensation, unemployment, disability, and other similar taxes imposed by any
Tax Authority, and any

                                      - 4 -
<Page>

interest, penalties, additions to tax, or additional amounts with respect to the
foregoing imposed on any taxpayer or consolidated, combined, or unitary group of
taxpayers.

"Governmental Authority" means any supranational, international, national,
federal, state, or local court, government, department, commission, board,
bureau, agency, official or other regulatory, administrative or governmental
authority, including The New York Stock Exchange, Inc. and any similar
self-regulatory body under applicable securities laws or regulations.

"Hospira" has the meaning set forth in the Preamble.

"Hospira Change of Control" means with respect to Hospira: (i) the acquisition
by a Third Party of thirty percent (30%) or more of the combined voting power of
the then outstanding voting securities of Hospira entitled to vote generally in
the election of directors; (ii) over any twenty-four (24) month period,
individuals who constitute the board of directors of Hospira as of the beginning
of the period (the "INCUMBENT BOARD") cease for any reason to constitute at
least a majority thereof, provided that any Person becoming a director during
such period whose election or nomination for election by Hospira's stockholders
was approved in advance by a vote of at least a majority of the Incumbent Board
(either by a specific vote or by approval of the proxy statement of Hospira in
which such Person is named as a nominee for director without objection of
nomination) will be, for purposes of this clause (ii), considered as though such
Person were a member of the Incumbent Board; (iii) the sale or transfer of all
or a substantial portion of the assets of Hospira that are related to Hospira's
performance pursuant to this Agreement (including a divestiture of Hospira's
rights to the Products sold in the Territory),

                                      - 5 -
<Page>

directly or indirectly through the sale or transfer of ownership interests in
the assets or the entity owning such assets; or (iv) a merger or combination as
a result of which Hospira's stockholders cease to own at least sixty percent
(60%) of the equity voting power of the merged or combined enterprise.

"Hospira Group" means Hospira and all Affiliates of Hospira.

"ICO Agreement" means the International Commercial Operations Agreement entered
into by and between Abbott and Hospira as the same may be amended.

"Indemnified Party" has the meaning ascribed to such term in Section 5.17(a).

"Indemnifying Party" has the meaning ascribed to such term in Section 5.17(a).

"Internal Distribution" has the meaning ascribed to such term in Section
3.01(b).

"IRS" means the United States Internal Revenue Service.

"Local Closing" means the transactions that occur on the Closing Date.

"Parties" means the parties to this Agreement.

"Person" means an individual, a general or limited partnership, a corporation, a
trust, a joint

                                      - 6 -
<Page>

venture, an unincorporated organization, a limited liability entity, any other
entity and any Governmental Authority.

"Post-Distribution Period" means any taxable period or portion of a taxable
period beginning after the Distribution Date.

"Pre-Distribution Period" means any taxable period or portion of a taxable
period ending on or before the Distribution Date.

"Prime Rate" means the rate which Citibank N.A. (or its successors or another
major money center commercial bank agreed to by the parties) announces from time
to time as its prime lending rate, as in effect from time to time.

"Private Letter Ruling" means the private letter ruling issued by the IRS on
December 4, 2003, in connection with the Contribution, Distribution, and related
transactions, including the request for such rulings together with all
supplemental filings and exhibits thereto submitted to the IRS on behalf of
Abbott or its subsidiaries in connection therewith.

"Puerto Rican Ruling" means the ruling, if any, issued by the Treasury
Department of Puerto Rico pursuant to the ruling request filed on behalf of
Abbott, Abbott Laboratories de Puerto Rico, Inc., Hospira, and Hospira Puerto
Rico LLC on ___________, 2004 with respect to the Puerto Rican Transaction,
together with all supplemental filings and exhibits thereto.

                                      - 7 -
<Page>

"Puerto Rican Transaction" has the meaning ascribed to such term in Section
3.01(a).

"Remitting Party" has the meaning ascribed to such term in Section 5.17(b).

"Responsible Party" has the meaning ascribed to such term in Section 5.17(b).

"Section 355(e) Event" has the meaning ascribed to such term in Section 3.01(b).

"Separation" has the meaning ascribed to such term in the first WHEREAS clause
hereof.

"Specified Action" has the meaning ascribed to such term in Section 4.02(b).

"Straddle Period" means any taxable period beginning on or before the
Distribution Date and ending after the Distribution Date.

"Tax" means: (i) any income, net income, gross income, gross receipts, profits,
capital stock, franchise, property, ad valorem, stamp, excise, severance,
occupation, service, sales, use, license, lease, transfer, import, export,
customs duties, value added, alternative minimum, estimated or other similar tax
(including any fee, assessment, or other charge in the nature of or in lieu of
any tax) imposed by any Tax Authority, and any interest, penalties, additions to
tax or additional amounts with respect to the foregoing imposed on any taxpayer
or consolidated, combined or unitary group of taxpayers; and (ii) any Employment
Tax.

                                      - 8 -
<Page>

"Tax Authority" means, with respect to any Tax, the governmental entity or
political subdivision thereof that imposes such Tax, and the agency (if any)
charged with the collection of such Tax for such entity or subdivision.

"Tax Benefit" means the reduction in Tax that should result from any item of
loss, deduction, or credit (or any other item), whether or not an actual
reduction in Tax occurs, including any interest with respect thereto or interest
that would have been payable but for such item, net of any Tax on such interest.
For purposes of calculating the amount of any Tax Benefit, the maximum statutory
rate (or rates, in the case of an item that affects more than one Tax)
applicable to each item of income, gain, loss, deduction, or credit (or any
other item) shall be used.

"Tax Contest" means an audit, review, examination, or any other administrative
or judicial proceeding with the purpose or effect of redetermining any Tax
(including any administrative or judicial review of any claim for refund).

"Tax Detriment" means the increase in Tax that should result from any item of
income or gain (or any other item), whether or not an actual increase in Tax
occurs, including any interest with respect thereto, net of any Tax savings
attributable to such interest. For purposes of calculating the amount of any Tax
Detriment, the maximum statutory rate (or rates, in the case of an item that
affects more than one Tax) applicable to each item of income, gain, loss,
deduction, or credit (or any other item) shall be used.

                                      - 9 -
<Page>

"Tax Package" means the information and documents in the possession of the
Hospira Group that are reasonably necessary for the preparation of a Tax Return
of the Abbott Group with respect to a Pre-Distribution Period, assembled in all
material respects in accordance with the standards that Abbott has heretofore
applied to divisions and Affiliates.

"Tax Records" means all records relating to any Tax, including without
limitation Tax Returns, journal vouchers, cash vouchers, general ledgers,
material contracts, Tax Return workpapers and schedules, appraisal reports,
authorizations for expenditures, and documents relating to rulings or other
Determinations by any Tax Authority.

"Tax Return" means any report of Tax due, any claims for refund of Tax paid, any
information return with respect to Tax, any election made with respect to Tax,
or any other similar report, statement, declaration, or document required to be
filed under the Code or other law with respect to Tax, including any
attachments, exhibits, or other materials submitted with any of the foregoing,
and including any amendments or supplements to any of the foregoing for any
taxpayer or consolidated, combined, or unitary group of taxpayers.

"TMDS Agreement" means any of the Transition Marketing and Distribution Services
Agreements by and between Hospira and a non-U.S. Affiliate of Abbott as the same
may be amended.

"Third Party" means any Person other than Abbott, any Abbott Affiliate, Hospira
and any Hospira Affiliate.

                                     - 10 -
<Page>

"Transition Period Tax" has the meaning ascribed to such term in Section 3.02.

"U.S. Transferred Employee" has the meaning set forth in the Employee Benefits
Agreement by and between Abbott and Hospira.

ARTICLE II.     RESPONSIBILITY FOR TAX

Section 2.01    Responsibility for Tax.

   (a)  Except as specifically provided in any of the agreements contemplated by
        the Distribution Agreement, including the EBA with respect to Employment
        Taxes, Abbott shall be responsible for, and shall indemnify and hold
        harmless the Hospira Group from any liability for (i) any Tax imposed by
        any Tax Authority on Abbott or an Abbott Affiliate, including Hospira
        and all Hospira Affiliates, for any Pre-Distribution Period, except any
        Covered Transaction Tax for which Hospira is responsible under Section
        3.01(b); and (ii) any Tax imposed by any Tax Authority on any member of
        the Abbott Group for any Post-Distribution Period, except any Transition
        Period Tax for which Hospira is responsible under Section 3.02.

   (b)  Except as specifically provided in any of the agreements contemplated by
        the Distribution Agreement, including the EBA with respect to Employment
        Taxes, Hospira shall be responsible for, and shall indemnify and hold
        harmless the Abbott Group from any liability for (i) any Tax imposed by
        any Tax Authority on Hospira or a Hospira Affiliate for any
        Post-Distribution Period; (ii) any Covered Transaction Tax for which

                                     - 11 -
<Page>

        Hospira is responsible under Section 3.01(b); and (iii) any Transition
        Period Tax for which Hospira is responsible under Section 3.02.

   (c)  The responsibility for any Tax incurred in a Straddle Period by any
        member of the Hospira Group shall be allocated between the
        Pre-Distribution Period and the Post-Distribution Period as if such
        member closed its financial accounting records as of the Effective Time
        and determined the Tax attributable to the Pre-Distribution Period by
        applying the method of tax accounting that has historically been used
        for the business of such member.

Section 2.02    Refunds, Tax Benefits, and Other Allocations

   (a)  Refunds and Carrybacks.

        (i)     Abbott Refunds. Except as provided in Section 2.02(a)(iv) below,
                Abbott shall be entitled to all refunds (including refunds paid
                by means of a credit against other or future Tax liabilities)
                and credits with respect to any Tax for which Abbott is
                responsible under Section 2.01(a).

        (ii)    Hospira Refunds. Hospira shall be entitled to all refunds
                (including refunds paid by means of a credit against other or
                future Tax liabilities) and credits with respect to any Tax for
                which Hospira is responsible under Section 2.01(b).

        (iii)   Payment of Refunds. Except as provided in Section 2.02(a)(iv),
                Hospira shall forward to Abbott, or reimburse Abbott for, any
                refunds due Abbott (pursuant to the terms of this Section
                2.02(a)) after receipt thereof (less any Tax Detriment
                attributable to such refunds), and Abbott shall forward to
                Hospira, or reimburse

                                     - 12 -
<Page>

                Hospira for, any refunds due Hospira (pursuant to the terms of
                this Section 2.02(a)) after receipt thereof (less any Tax
                Detriment attributable to such refunds). In the case of a refund
                received in the form of a credit against other or future Tax
                liabilities, reimbursement with respect to such refund shall be
                due in each case on the due date for payment of the Tax against
                which such refund has been credited. Any payment required to be
                made pursuant to this Section 2.02(a)(iii) shall be made within
                thirty (30) days of the receipt of the refund. If Abbott
                reasonably so requests, Hospira, at Abbott's expense, shall file
                for and pursue any refund to which Abbott is entitled under this
                Section 2.02(a). If Hospira reasonably so requests, Abbott, at
                Hospira's expense, shall file for and pursue any refund to which
                Hospira is entitled under this Section 2.02(a). The Party making
                a payment pursuant to this Section 2.02(a)(iii) must deliver
                with the payment a statement describing in reasonable detail the
                basis for the calculation of the amount being paid.

        (iv)    Carrybacks.

                                     - 13 -
<Page>

            1)  The Hospira Group shall be entitled to any refund of Abbott's
                Tax for a Pre-Distribution Period resulting from carrying back
                any item of loss, deduction or credit that arises in any
                Post-Distribution Period of Hospira only to the extent that (A)
                Abbott has no item of loss, deduction, or credit that can be
                carried back to such taxable period and (B) such carryback does
                not have a material adverse impact on Abbott, as reasonably
                determined by Abbott. If Abbott receives any such refund, it
                shall pay the portion thereof to which Hospira is entitled
                within thirty (30) days of the later of (C) a Determination with
                respect to Abbott's Tax for such Pre-Distribution Period or (D)
                a Determination with respect to Hospira's Tax for the
                Post-Distribution Period that gave rise to the refund received
                by Abbott; PROVIDED, HOWEVER, that if Hospira provides Abbott
                with a letter of credit in a form reasonably acceptable to
                Abbott and issued by a major money center commercial bank
                reasonably acceptable to Abbott not expiring before the later of
                clause (C) or (D) of this Section 2.02(a)(iv)(1), then Abbott
                shall pay to Hospira that portion of the refund covered by the
                letter of credit no later than thirty (30) days after receipt of
                the refund or of the letter of credit, whichever is later.

                                     - 14 -
<Page>

            2)  If Hospira has a loss or other Tax attribute for any
                Post-Distribution Period that is to be carried back to any
                Pre-Distribution Period, Hospira shall notify Abbott that such
                item should be carried back. Such notification shall include a
                description in reasonable detail of the grounds for the refund
                and the amount thereof, and a certification by an appropriate
                officer of Hospira setting forth Hospira's belief, based on a
                thorough examination of the facts and Tax law relating to the
                Tax treatment of such item, that the Tax treatment of such item
                is supported by "substantial authority" within the meaning of
                Section 6662 of the Code (and the Treasury Regulations
                thereunder) or, where applicable, any analogous provision of
                state or local law. Abbott, at Hospira's expense, shall
                cooperate with Hospira in connection with the filing and
                processing of any Hospira carryback and shall provide Hospira
                with copies of all correspondence related thereto.

            3)  If Abbott pays any amount to Hospira under Section
                2.02(a)(iv)(1) and, as a result of a subsequent Determination,
                Hospira is not entitled to all or any part of such amount,
                Abbott shall notify Hospira of the amount to be repaid to Abbott
                and provide a description in reasonable detail of the manner in
                which such amount was calculated. Hospira shall pay such amount
                to Abbott within thirty (30) days of such notification.

                                     - 15 -
<Page>

            4)  Any payment required to be made by Abbott pursuant to this
                Section 2.02(a)(iv) shall bear interest at the Prime Rate plus
                two percent from the date a refund is received by Abbott. Any
                payment required to be made by Hospira pursuant to this Section
                2.02(a)(iv) shall bear interest at the Prime Rate plus two
                percent beginning thirty (30) days after Abbott notifies Hospira
                of the amount to be repaid. Such interest shall be paid at the
                same time as the payment to which it relates.

   (b)  Effect of Audit Adjustments.

        Notwithstanding Section 2.01 --

        (i)     Payments by Hospira to Abbott. Except as provided in Sections
                3.01(b) and 3.02, if as a result of a Determination, any
                adjustment shall be made to any Tax Return relating, in whole or
                in part, to Tax for which any member of the Abbott Group is
                responsible, and if such adjustment results in both (x) a Tax
                Detriment to any member of the Abbott Group for any taxable
                period and (y) a Tax Benefit to any member of the Hospira Group
                for any Post-Distribution Period, then Hospira shall pay to
                Abbott an amount equal to the lesser of the Tax Benefit for each
                taxable period and the Corresponding Portion of the Tax
                Detriment.

        (ii)    Payments by Abbott to Hospira. If as a result of a
                Determination, any adjustment shall be made to any Tax Return
                relating, in whole or in part, to Tax for which the Hospira
                Group is responsible, and if such adjustment results in both (x)
                a Tax Detriment to any member of the Hospira Group for any
                Post-Distribution Period and (y) a Tax Benefit to any member of
                the Abbott Group for any taxable period,

                                     - 16 -
<Page>

                then Abbott shall pay to Hospira an amount equal to the lesser
                of the Tax Benefit for such taxable period and the Corresponding
                Portion of the Tax Detriment.

        (iii)   Timing of Payments. Any payment required to be made pursuant to
                this Section 2.02(b), shall be made the later of (x) thirty (30)
                days after the Determination that results in such payment
                pursuant to this Section 2.02(b) and (y) the due date of the Tax
                Return that includes the Tax Benefit that gives rise to the
                requirement for such payment.

   (c)  Other Allocations

        (i)     Research and Experimentation Credit Base Period. Abbott shall
                reasonably make the allocations to Hospira required under
                Section 41(f)(3) of the Code. Hospira agrees that it shall not
                file any Tax Return that is inconsistent with the amount of
                qualified research expenditures and gross receipts allocated to
                it by Abbott.

        (ii)    Allocation of Earnings and Profits. The allocation of earnings
                and profits between Abbott and Hospira shall be reasonably
                determined by Abbott pursuant to Section 312(h) of the Code and
                the Treasury Regulations thereunder. A preliminary allocation of
                earnings and profits through December 31, 2002, shall be
                provided no later than forty-five (45) days after Abbott
                receives the allocation from the public accounting firm that
                prepares such allocation, but no later than September 30, 2004.
                The allocation of earnings and profits from January 1, 2003,
                through the Distribution Date shall be provided no later than
                December 31, 2005.

                                     - 17 -
<Page>

        (iii)   Revised Allocations. The allocations made under this Section
                2.02(c) shall be revised by Abbott to reflect each subsequent
                Determination that affects such allocations for any
                Pre-Distribution Period. Each revised calculation shall be
                provided to Hospira within 120 days of the Determination to
                which the revision relates.

        (iv)    Review of Allocations. Hospira shall have the right to review
                the accuracy, but not the methodology, of any allocation made
                under this Section 2.02(c). Hospira shall notify Abbott of any
                disagreement within forty-five (45) days of being notified of
                any allocation. Any dispute shall be resolved pursuant to the
                procedures provided by this Agreement.

Section 2.03    Option Deductions.

   (a)  Except as provided in Section 2.03(b), upon the exercise of any option
        to purchase Abbott stock, Abbott shall claim any Tax deduction
        attributable to such exercise on its Tax Returns and Hospira shall not
        claim such deduction on its Tax Returns. On the exercise of any option
        to purchase Hospira stock, Hospira shall claim any Tax deduction
        attributable to such exercise on its Tax Returns and Abbott shall not
        claim such deduction on its Tax Returns.

   (b)  Abbott and Hospira agree to file all Tax Returns on the basis that (i)
        any Abbott restricted stock and (ii) any option to purchase Abbott stock
        held by an employee of Hospira was granted to such individual by Abbott
        in connection with the performance of services for Abbott. To the extent
        any Tax deduction claimed by Abbott attributable to the exercise of such
        options is disallowed to Abbott, and a Tax Authority makes a
        Determination that

                                     - 18 -
<Page>

        Hospira is entitled to such deduction, Abbott shall notify Hospira of
        the receipt of such Determination, promptly after receipt thereof, and
        Hospira shall pay to Abbott the lesser of the amount of its Tax Benefit
        and the amount of the corresponding Tax Detriment in accordance with
        Section 2.02(b). To the extent any Tax deduction claimed by Hospira
        attributable to the exercise of an option to purchase Hospira stock is
        disallowed to Hospira, and a Tax Authority makes a Determination that
        Abbott is entitled to such deduction, Hospira shall notify Abbott of the
        receipt of such Determination, promptly after receipt thereof, and
        Abbott shall pay to Hospira the lesser of the amount of its Tax Benefit
        and the amount of the corresponding Tax Detriment in accordance with
        Section 2.02(b). The provisions of this Section 2.03 shall apply MUTATIS
        MUTANDIS to restricted shares, disqualifying dispositions to which
        Section 421(c) of the Code applies, and other equity based compensation.

Section 2.04    Tax Returns.

   (a)  Abbott shall prepare and timely file all Tax Returns for
        Pre-Distribution Periods for Abbott and all of its Affiliates, including
        Hospira and all of its Affiliates, and all Tax Returns for Straddle
        Periods for all members of the Abbott Group. In connection with each
        federal, state, local, and foreign Tax Return that is required under
        this Agreement to be filed by Abbott for taxable periods ending in 2004,
        Hospira shall provide Abbott, no later than November 30, 2004, with a
        Tax Package for the purpose of preparing such Tax Return. Hospira shall
        provide a supplemental Tax Package with respect to each such Tax Return,
        if necessary, no later than January 31, 2005, and Hospira shall timely
        furnish to Abbott additional Tax information and documents as Abbott may
        reasonably request. With respect to any information required to be
        provided by Hospira pursuant to this

                                     - 19 -
<Page>

        Section 2.04(a), (i) Abbott shall utilize such information in the
        preparation of the appropriate Tax Returns as provided by Hospira,
        except to the extent (a) Hospira provides its prior written consent to
        change any such information, or (b) Abbott determines in good faith that
        such information is inaccurate or incomplete in a material respect, and
        (ii) Hospira agrees to indemnify and hold harmless Abbott and its
        Affiliates from and against any cost, fine, penalty, or other expense of
        any kind attributable to the misconduct or negligence of Hospira or any
        of its Affiliates in supplying Abbott with inaccurate or incomplete
        information. An appropriate officer of Hospira shall provide a
        certification that, to such officer's best knowledge and belief, any and
        all information provided pursuant to this Section 2.04(a) is accurate
        and complete. If Hospira fails to provide any information required by
        this Section 2.04(a) within the time period specified, Abbott may file
        the applicable Tax Returns based on the information available at the
        time such Tax Returns are due and Hospira shall indemnify and hold
        harmless Abbott and its Affiliates from Taxes or other costs imposed on
        Abbott or any of its Affiliates but only to the extent resulting from
        Hospira's failure to provide such information in a timely manner. In
        addition, Hospira shall provide Abbott with all documents and
        information, and make available employees and officers of Hospira and
        Hospira Affiliates as Abbott reasonably requests to prepare and file any
        Tax Return for any Pre-Distribution Period (including any claims for
        refunds described in Section 2.02(a)) or to conduct any Tax Contest with
        respect to any such Tax Return.

   (b)  Hospira shall prepare and timely file all Tax Returns for Straddle
        Periods for all members of the Hospira Group. If Abbott is responsible
        under Section 2.01(a) for a portion of any Tax reported on a Straddle
        Period Tax Return for any member of the Hospira Group,

                                     - 20 -
<Page>

        Hospira shall provide Abbott with a copy of such Tax Return at least
        thirty (30) days prior to its due date. Abbott shall notify Hospira of
        any disagreement within 20 days of Abbott's receipt of such Tax Return.
        Any dispute shall be resolved pursuant to the procedures provided by
        this Agreement.

   (c)  Hospira shall not file (or allow any member of the Hospira Group to
        file) any amended Tax Return for any Pre-Distribution Period.

   (d)  Abbott shall provide Hospira with notice of any Tax election that Abbott
        intends to file for any member of the Hospira Group on any Tax Return
        for any Pre-Distribution Period within forty-five (45) days before such
        Tax Return will be filed. Hospira shall have the right to review such
        elections and request, within 15 days of such notice, that an
        alternative election be made. If Abbott reasonably determines that such
        alternative election will not result in any increased Tax liability or
        reduced Tax attribute of Abbott or any Abbott Affiliate, Abbott shall
        comply with such request.

Section 2.05    Cooperation, Exchange of Information, and Tax Records.

   (a)  Cooperation and Exchange of Information. Each Party shall provide to the
        other such cooperation and information as reasonably may be requested in
        connection with (i) filing any Tax Return, amended return or claim for
        refund, (ii) determining a liability for Tax or a right to a refund of
        Tax, or (iii) participating in or conducting any Tax Contest. Such
        cooperation and information shall include providing copies of relevant
        Tax Records. Each Party shall devote the personnel and resources
        necessary in order to carry out this Section 2.05(a) and shall make its
        employees available on a mutually convenient basis to

                                     - 21 -
<Page>

        provide explanations of any documents or information provided hereunder.
        Each Party shall carry out its responsibilities under this Section
        2.05(a) charging to the other only the out-of-pocket costs actually
        incurred. Any information obtained under this Section 2.05(a) shall be
        kept in strict confidence, with at least the same degree of care that
        applies to Abbott's confidential and proprietary information pursuant to
        policies in effect as of the Effective Time, except as otherwise may be
        necessary in connection with the filing of Tax Returns or claims for
        refund or in conducting an audit or other proceeding. Hospira shall
        execute all necessary or appropriate forms, including powers of
        attorney, reasonably requested by Abbott in connection with any action
        taken by Abbott pursuant to this Agreement.

   (b)  Record Retention. Each of Abbott and Hospira shall retain all Tax
        Records in its possession as of the Effective Time relating to any
        Pre-Distribution Period that are relevant to the other Party for
        purposes described in Section 2.05(a) until such time as the other Party
        shall consent to the disposition of such Tax Records, which consent
        shall not be withheld unreasonably.

Section 2.06    Tax Contests.

   (a)  Notice. Each Party shall provide prompt notice to the other Party of any
        pending or threatened Tax audit, assessment, or proceeding, or other Tax
        Contest, of which it becomes aware, related to Tax for which it is
        indemnified by the other Party hereunder. Such notice shall contain
        factual information (to the extent known) describing any asserted Tax
        liability in reasonable detail and shall be accompanied by copies of any
        notice and other documents received from any Tax Authority with respect
        to any such

                                     - 22 -
<Page>

        matters. If an Indemnified Party has knowledge of an asserted Tax
        liability with respect to a matter for which it is to be indemnified
        hereunder and such Party fails to give the Indemnifying Party prompt
        notice of such asserted Tax liability, then (i) if the Indemnifying
        Party is precluded from contesting the asserted Tax liability in any
        forum as a result of the failure to give prompt notice, the Indemnifying
        Party shall have no obligation to indemnify the Indemnified Party for
        any Tax resulting from such assertion of Tax liability, and (ii) if the
        Indemnifying Party is not precluded from contesting the asserted Tax
        liability in any forum, but such failure to give prompt notice results
        in a monetary detriment to the Indemnifying Party, then any amount that
        the Indemnifying Party is otherwise required to pay the Indemnified
        Party pursuant to this Agreement shall be reduced by the amount of such
        detriment.

   (b)  Control of Tax Contests.

        (i)     Hospira. Hospira shall have full responsibility and discretion
                in conducting, including settling, any Tax Contest involving a
                Tax for which it is responsible under Section 2.01(b), except
                for any Tax Contest involving any Covered Transaction Tax for
                which Hospira is responsible under Section 3.01(b) and any
                Transition Period Tax for which Hospira is responsible under
                Section 3.02.

                                     - 23 -
<Page>

        (ii)    Abbott. Abbott shall have full responsibility and discretion in
                conducting, including settling, any Tax Contest involving (x)
                any Tax for which it is responsible under Section 2.01(a), (y)
                any Covered Transaction Tax for which Hospira is responsible
                under Section 3.01(b), except as provided in paragraph (iii),
                below and (z) any Transition Period Tax for which Hospira is
                responsible under Section 3.02. Abbott shall consult in good
                faith with Hospira in connection with any Tax Contest described
                in clauses (y) or (z) of this Section 2.06(b)(ii).

        (iii)   Covered Transaction Taxes. Hospira shall have the right to
                participate in the conduct of a Tax Contest related to Covered
                Transactions Taxes as a result of the application of Section
                355(e) of the Code if, and only if, (x) Hospira has acknowledged
                in writing its liability for such Covered Transaction Tax, (y)
                Hospira shall have provided Abbott with a letter of credit in a
                form reasonably acceptable to Abbott and issued by a major money
                center commercial bank reasonably acceptable to Abbott, not
                expiring before a Determination has occurred with respect to
                Abbott's Tax for the Post-Distribution Period that gave rise to
                the Covered Transactions Tax at issue, and in an amount equal to
                the maximum amount of Covered Transaction Tax at issue in the
                Tax Contest and (z) no Tax Return of any member of the Abbott
                Group with respect to which any member of the Abbott Group may
                reasonably be viewed as having an actual or potential liability
                for any Tax not indemnified against by Hospira is held open as a
                result of such Tax Contest. Abbott shall not settle any Tax
                Contest described in this paragraph (iii) without the consent of
                Hospira, which consent shall not be unreasonably withheld.

                                     - 24 -
<Page>

ARTICLE III.    TRANSACTIONS TAX

Section 3.01    Transactions Tax.

   (a)  General. Except as otherwise provided in Section 3.01(b), Abbott shall
        be responsible for, and shall indemnify and hold harmless the Hospira
        Group from any and all (i) liabilities sustained by Abbott or Hospira as
        a result of the Distribution failing to qualify as Tax-free to the
        Abbott shareholders pursuant to Section 355(a) of the Code, and (ii)
        federal, state, local, and foreign Tax imposed by any Tax Authority on
        Abbott or any Abbott Affiliate as a result of (w) the failure of any of
        the transactions described in the Private Letter Ruling to be treated as
        provided in such ruling; (x) the failure of the distribution of the
        stock of Hospira Ltd., a Bahamas corporation, (the "Bahamian
        Distribution") to qualify for Tax-free treatment under Sections 355 and
        361 of the Code; (y) the failure of any of the transactions described in
        the Puerto Rican Ruling (the "Puerto Rican Transaction") to be treated
        as provided in such ruling; and (z) the inclusion, or taking into
        account, of any income or gain by Abbott or its Affiliates (including
        any member of the Hospira Group) under Treasury Regulations Section
        1.1502-13 or 1.1502-19 (or any corresponding provisions of other
        applicable Tax laws) as a result of the Distribution (collectively
        "Covered Transaction Tax").

   (b)  Inconsistent Acts and Events. Hospira shall be responsible for, and
        shall indemnify and hold harmless the Abbott Group from and against any
        liability for, any Covered Transaction Tax (including without limitation
        reasonable attorney fees and other costs incurred in connection
        therewith) resulting from (i) any breach by any member of the

                                     - 25 -
<Page>

        Hospira Group of any of the representations or covenants under Article
        IV hereof, (ii) any Specified Action performed by any member of the
        Hospira Group (whether or not Section 4.02(e) is complied with), and
        (iii) any Section 355(e) Event with respect to Hospira (whether or not
        such Section 355(e) Event is caused by a Specified Action). A Section
        355(e) Event with respect to Hospira means any event, involving the
        stock of Hospira or a Hospira Affiliate or assets of any member of the
        Hospira Group, that causes the Distribution, the distribution described
        in the Private Letter Ruling by Abbott Laboratories, Inc. of the stock
        of Hospira Worldwide, Inc. (the "Internal Distribution"), or the
        Bahamian Distribution to be a taxable event to any member of the Abbott
        Group as the result of the application of Section 355(e) of the Code.

Section 3.02    Transition Period Tax. Notwithstanding Section 2.02(b)(i),
if, as a result of a Determination, any member of the Abbott Group incurs a
Tax Detriment for a Post-Distribution Period with respect to any transaction
undertaken pursuant to any of the TMDS Agreements or the ICO Agreement, other
than a transaction to effect a Local Closing, Hospira shall be responsible
for, and shall indemnify and hold harmless the Abbott Group from and against
any liability for, an amount equal to 50 percent of the sum of such Tax
Detriment, reasonable attorney fees, and other costs incurred therewith (the
"Transition Period Tax") whether or not any Tax Benefit results to any member
of the Hospira Group; PROVIDED, HOWEVER, that Hospira shall indemnify Abbott
for 100 percent of any Transition Period Tax if there is: (i) a merger or
consolidation of Hospira; (ii) the sale of all or substantially all of the
assets of Hospira; or (iii) the acquisition by a Third Party of at least 30%
of the combined voting power of the then-outstanding securities of Hospira
entitled to vote generally in the election of directors, in each case so long
as the resulting, surviving or transferee person assumes all the obligations
of the assignor hereunder by operation of law or pursuant to an agreement in
form and substance reasonably satisfactory to Abbott and Abbott agrees to
waive this proviso (which agreement shall not be unreasonably withheld,
delayed, or conditioned). It shall not be deemed to be unreasonable for Abbott
to withhold consent to such an assignment on the basis that the proposed
assignee is a competitor of Abbott.

                                     - 26 -
<Page>

ARTICLE IV.     REPRESENTATIONS AND COVENANTS

Section 4.01    Representations.

   (a)  Abbott represents that, as of the date of this Agreement, neither it nor
        any of its Affiliates knows of any fact that would jeopardize the Tax
        treatment of the transactions provided by the Private Letter Ruling or
        the Puerto Rican Ruling, or that otherwise would result in a Covered
        Transaction Tax.

   (b)  Hospira represents that, as of the date of this Agreement, neither it
        nor any of its Affiliates knows of any fact that would jeopardize the
        Tax treatment of the transactions provided by the Private Letter Ruling
        or the Puerto Rican Ruling, or that otherwise would result in a Covered
        Transaction Tax.

   (c)  Abbott represents that, as of the date of this Agreement, neither it nor
        any of its Affiliates has any plan or intention to take any action that
        is inconsistent with the Tax treatment of the transactions provided by
        the Private Letter Ruling or the Puerto Rican Ruling, or that otherwise
        would result in a Covered Transaction Tax.

   (d)  Hospira represents that, as of the date of this Agreement, neither it
        nor any of its Affiliates has any plan or intention to take any action
        that is inconsistent with the Tax treatment of the transactions provided
        by the Private Letter Ruling or the Puerto Rican Ruling, or that
        otherwise would result in a Covered Transaction Tax.

   (e)  Hospira represents that, as of the date of this Agreement, neither it
        nor any of its Affiliates has entered into any agreement, understanding,
        arrangement, or substantial negotiation with respect to any transaction
        or event (including stock issuances, option

                                     - 27 -
<Page>

        grants, capital contributions, acquisitions, and changes in the voting
        power of any of its stock), that may cause Section 355(e) of the Code to
        apply to the Distribution, the Internal Distribution, or the Bahamian
        Distribution.

Section 4.02    Covenants.

   (a)  Successor Employer. In connection with the Distribution, Abbott and
        Hospira covenant and agree to treat Hospira as a "successor employer"
        pursuant to the alternate procedures in Revenue Procedure 96-60 for
        payroll Tax reporting purposes. Hospira shall assume reporting
        responsibilities for filing Forms W-2 and other payroll Tax forms for
        the U.S. Transferred Employees for the entire 2004 calendar year. Abbott
        covenants and agrees to cooperate in the administration and
        implementation of the alternate procedures for successor payroll
        processing provided by Revenue Procedure 96-60 and not to report such
        compensation on any basis inconsistent therewith to any governmental
        authority. Hospira covenants and agrees to indemnify and reimburse
        Abbott for any costs of responding to any notices received from any
        governmental authority, the costs of defending the position that Hospira
        qualifies as a "successor employer" before any governmental agency, and
        any additional Taxes, fines, penalties, and/or interest imposed on
        Abbott if such position ultimately is found to be incorrect.

   (b)  Conduct. Hospira covenants and agrees that it shall not take, and it
        shall cause its Affiliates to refrain from taking, any action that
        reasonably may be expected to result in any increased Tax liability or
        reduced Tax attribute of any member of the Abbott Group. This includes
        taking any action that is inconsistent with the Tax treatment of the
        transactions provided by the Private Letter Ruling or the Puerto Rican
        Ruling (any such

                                     - 28 -
<Page>

        action, including any action referred to in Section 4.02(b)(i) through
        (iii), is referred to in this Agreement as a "Specified Action").
        Without limiting the foregoing:

        (i)     Specified Actions. Any time before the second anniversary of the
                Distribution Date, Hospira shall not (and shall cause its
                Affiliates to not) (A) liquidate, merge, or consolidate with or
                into any corporation that was not already wholly owned by
                Hospira or by a wholly owned subsidiary of Hospira prior to such
                transaction; (B) issue any of its capital stock in one or more
                transactions, other than (i) issuances to employees, directors,
                or independent contractors in connection with the performance of
                services for Hospira (that are not excessive by reference to the
                services performed) which issuances either (x) are with respect
                to the exercise of options of Hospira that are substituted for
                Abbott options or (y) satisfy the requirements of Treasury
                Regulations Section 1.355-7T(d)(6) to not be treated for
                purposes of Section 355(e) of the Code to be part of a plan or
                series of related transactions that includes the Distribution,
                the Internal Distribution, or the Bahamian Distribution, or (ii)
                issuances of stock to a retirement plan qualified under Section
                401(a) or 403(a) of the Code in a transaction that satisfies the
                requirements of Treasury Regulations Section 1.355-7T(d)(7); (C)
                redeem, purchase, or otherwise reacquire any of its capital
                stock in one or more transactions; (D) change the voting rights
                of any of its stock; (E) issue any options to acquire Hospira
                Shares other than options that satisfy the requirements of
                Treasury Regulations Section 1.355-7T(e)(3)(ii); (F) sell,
                exchange, distribute, or otherwise dispose of, other than in the
                ordinary course of business, all or a substantial part of the
                assets of any of the trades or businesses relied on to satisfy

                                     - 29 -
<Page>

                Section 355(b) of the Code; or (G) discontinue or cause to be
                discontinued the active conduct of any of the trades or
                businesses relied on to satisfy Section 355(b) of the Code.
                Notwithstanding the foregoing, clauses (A) through (E) of this
                Section 4.02(b)(i) shall not apply unless there are transactions
                described in such clauses any time before the second anniversary
                of the Distribution Date that result in one or more Persons
                acquiring directly or indirectly stock representing, in the
                aggregate, 25 percent or greater interest in Hospira (as defined
                in Sections 355(d)(4) and 355(e) of the Code).

        (ii)    No Inconsistent Actions. Regardless of any change in
                circumstances, Hospira covenants and agrees that it shall not
                take any action (and it shall cause its Affiliates to refrain
                from taking any action) that is inconsistent with any factual
                statements or representations in the Private Letter Ruling or
                the Puerto Rican Ruling on or before the second anniversary of
                the Distribution Date other than as permitted in this Section
                4.02. For this purpose an action is considered inconsistent with
                a representation if the representation states that there is no
                plan or intention to take such action.

                                     - 30 -
<Page>

        (iii)   Section 355(e). Without in any manner limiting paragraph (i) or
                (ii) of Section 4.02(b), Hospira covenants and agrees that,
                through the second anniversary of the Distribution Date, it
                shall refrain from entering into (and it shall cause its
                Affiliates to refrain from entering into) any agreement,
                understanding, arrangement, or substantial negotiation with
                respect to any transaction or event (including stock issuances,
                option grants, capital contributions, acquisitions, or changes
                in the voting power of any of its stock), that could reasonably
                be expected to cause Section 355(e) of the Code to apply to the
                Distribution, the Internal Distribution, or the Bahamian
                Distribution.

   (c)  Amended or Supplemental Rulings. Hospira covenants and agrees that it
        shall refrain from filing, and it shall cause its Affiliates to refrain
        from filing, a request for any amendment or supplement to the Private
        Letter Ruling or the Puerto Rican Ruling subsequent to the Distribution
        Date without the consent of Abbott, which consent shall not be withheld
        unreasonably.

   (d)  Tax Returns. Each of Abbott and Hospira covenants and agrees that it
        shall refrain from taking, and it shall cause its Affiliates to refrain
        from taking, any position on a Tax Return that is inconsistent with (i)
        the Tax treatment of the transactions provided by the Private Letter
        Ruling, (ii) the Contribution qualifying for Tax-free treatment under
        Section 361, (iii) the Tax treatment of the transactions provided by the
        Puerto Rican Ruling, (iv) the pricing provisions of the TMDS Agreements
        and the ICO Agreement, (v) the allocation of the benefits and burdens of
        Hospira assets and liabilities pursuant to Section 2.03 of the
        Distribution Agreement and Sections 2.2 and 3.1 of the ICO Agreement, or
        (vi) the documents effecting any transaction undertaken in connection

                                     - 31 -
<Page>

        with the Separation that is not addressed by the Private Letter Ruling.

   (e)  Exception. Notwithstanding the foregoing, Hospira shall be permitted to
        take an action inconsistent with Section 4.02(b), if, prior to taking
        such action, Hospira provides notification to Abbott of its plans with
        respect to such action and promptly responds to any inquiries by Abbott
        following such notification, and (unless Abbott agrees otherwise in
        writing) either:

        (i)     In the case of the Distribution or the Internal Distribution,
                Hospira obtains a supplemental ruling with respect to the action
                from the Internal Revenue Service that is reasonably
                satisfactory to Abbott (except that Hospira shall not submit any
                supplemental ruling request if Abbott determines in good faith
                that filing such request could have a materially adverse effect
                on Abbott), on the basis of facts and representations consistent
                with the facts at the time of such action, that such action will
                not affect the Tax treatment of the transactions provided by the
                Private Letter Ruling,

        (ii)    In case of the Distribution, the Internal Distribution, or the
                Bahamian Distribution, Hospira obtains an opinion, reasonably
                acceptable to Abbott, of an independent nationally recognized
                Tax counsel, reasonably acceptable to Abbott, on the basis of
                facts and representations consistent with the facts at the time
                of such action, that such action will not affect the Tax
                treatment of the transactions provided by the Private Letter
                Ruling or the intended Tax treatment of the Bahamian
                Distribution, or

        (iii)   In case of the Puerto Rican Transaction, Hospira obtains:

                                     - 32 -
<Page>

                (a)  a supplemental ruling with respect to the action from the
                     Puerto Rican Tax Authority that is reasonably satisfactory
                     to Abbott (except that Hospira shall not submit any
                     supplemental ruling request if Abbott determines in good
                     faith that filing such request could have a materially
                     adverse effect on Abbott or any of its Affiliates), or

                (b)  an opinion, reasonably acceptable to Abbott, of an
                     independent Tax counsel, reasonably acceptable to Abbott,

            on the basis of facts and representations consistent with the facts
            at the time of such action, that such action will not affect the Tax
            treatment of the transactions provided by the Puerto Rican Ruling.

        Notwithstanding anything to the contrary in this Agreement, Hospira
shall be responsible for, and shall indemnify Abbott and hold Abbott harmless
from, any Covered Transaction Tax resulting from a Specified Action of Hospira
or any of Hospira's Affiliates, regardless of whether the exception of this
Section 4.02(e) is satisfied with respect to such act.

Section 4.03    No Continuing Liability for Former Members.

   (a)  Abbott Affiliates. If an Abbott Affiliate ceases to be a member of the
        Abbott Group as a result of a sale or exchange of all of the stock of
        such member, other than an exchange for which the consideration received
        by Abbott is the stock of Abbott or an Abbott Affiliate, the departing
        Abbott Affiliate shall be released from its obligations under this
        Agreement upon its departure from the Abbott Group.

                                     - 33 -
<Page>

   (b)  Hospira Affiliates. If a Hospira Affiliate ceases to be a member of the
        Hospira Group as a result of a sale or exchange of all of the stock of
        such member, other than an exchange for which the consideration received
        by Hospira is the stock of Hospira or a Hospira Affiliate, the departing
        Hospira Affiliate shall be released from its obligations under this
        Agreement upon its departure from the Hospira Group; provided, however,
        that no member of the Hospira Group shall be released from any
        obligations under Section 2.01(b)(ii) hereof unless approved in writing
        by Abbott, which approval shall not be unreasonably withheld.

ARTICLE V.      MISCELLANEOUS PROVISIONS

Section 5.01    Counterparts; Entire Agreement; Corporate Power; Facsimile
                Signatures.

   (a)  Counterparts. This Agreement may be executed in one or more
        counterparts, all of which shall be considered one and the same
        agreement.

   (b)  Entire Agreement. This Agreement and the exhibits hereto contain the
        entire agreement between the Parties with respect to the subject matter
        hereof, supersede all previous agreements, negotiations, discussions,
        writings, understandings, commitments and conversations with respect to
        such subject matter and there are no agreements or understandings
        between the Parties other than those set forth or referred to herein.
        Notwithstanding any other provisions in the Distribution Agreement or
        any other agreement entered into in connection with the Distribution
        (except the EBA) to the contrary, in the event and to the extent that
        there is a conflict between the provisions of this Agreement and the
        provisions of the Distribution Agreement or any other agreement

                                     - 34 -
<Page>

        entered into in connection with the Distribution (except the EBA), the
        provisions of this Agreement shall control.

   (c)  Corporate Power. Abbott represents on behalf of itself and, to the
        extent applicable, each Abbott Affiliate and Hospira represents on
        behalf of itself and, to the extent applicable, each Hospira Affiliate
        as follows:

        (i)     each such Person has the requisite corporate or other power and
                authority and has taken all corporate or other action necessary
                in order to execute, deliver and perform this Agreement to which
                it is a Party and to consummate the transactions contemplated
                hereby and thereby; and

        (ii)    this Agreement to which it is a Party has been duly executed and
                delivered by it and constitutes a valid and binding agreement of
                it enforceable in accordance with the terms thereof.

   (d)  Facsimile Signatures. Each Party acknowledges that it and the other
        Party may execute this Agreement or amendment hereto by facsimile, stamp
        or mechanical signature. Each Party expressly adopts and confirms each
        such facsimile, stamp or mechanical signature made in its respective
        name as if it were a manual signature, agrees that it shall not assert
        that any such signature is not adequate to bind such Party to the same
        extent as if it were signed manually and agrees that at the reasonable
        request of the other Party at any time it shall as promptly as
        reasonably practicable cause this Agreement or any amendment hereto to
        be manually executed (any such execution to be as of the date of the
        initial date thereof).

Section 5.02    Governing Law. This Agreement shall be governed by and construed
and

                                     - 35 -
<Page>

interpreted in accordance with the laws of the State of Illinois irrespective of
the choice of laws principles of the State of Illinois, as to all matters,
including matters of validity, construction, effect, enforceability, performance
and remedies.

Section 5.03    Assignability. This Agreement shall be binding upon and inure
to the benefit of the Parties, respectively, and their respective successors and
permitted assigns; PROVIDED, HOWEVER, that neither Party may assign its rights
or delegate its obligations under this Agreement without the express prior
written consent of the other Party hereto. Notwithstanding the foregoing, this
Agreement shall be assignable in whole in connection with a merger or
consolidation or the sale of all or substantially all of the assets of a Party
so long as the resulting, surviving or transferee Person assumes all the
obligations of the relevant Party thereto by operation of law or pursuant to an
agreement in form and substance reasonably satisfactory to the other Party.

Section 5.04    Third Party Beneficiaries. The provisions of this Agreement are
solely for the benefit of the Parties and their respective Affiliates, after
giving effect to the Distribution, and are not intended to confer upon any
Person except the Parties and their respective Affiliates, after giving effect
to the Distribution, any rights or remedies hereunder; and (b) there are no
other third party beneficiaries of this Agreement and this Agreement shall not
provide any other third party with any remedy, claim, liability, reimbursement,
claim of action or other right in excess of those existing without reference to
this Agreement.

Section 5.05    Notice. All notices or other communications under this
Agreement must be in writing and shall be deemed to be duly given: (a) when
delivered in person; (b) upon transmission via confirmed facsimile transmission,
provided that such transmission is followed

                                     - 36 -
<Page>

by delivery of a physical copy thereof in person, via U.S. first class mail, or
via a private express mail courier; or (c) two days after deposit with a private
express mail courier, in any such case addressed as follows:

        If to Abbott, to:

        Abbott Laboratories

        100 Abbott Park Road

        D-322 AP6D

        Abbott Park, IL 60064-3500

        Facsimile:

        Attention: General Counsel

        With a copy to:

        Abbott Laboratories

        100 Abbott Park Road

        D-367 AP6D

        Abbott Park, IL 60064-6057

        Facsimile:

        Attention: Vice President-Tax

        If to Hospira, to:

        Hospira, Inc.

        275 N. Field Drive

        Lake Forest, Illinois 60045

                                     - 37 -
<Page>

        Facsimile:

        Attention: General Counsel

        With a copy to:

        Hospira Inc.

        Hospira, Inc.

        275 N. Field Drive

        Lake Forest, Illinois 60045

        Facsimile:

        Attention: Vice President - Tax.

Any Party may, by notice to the other Party, change the address to which such
notices are to be given.

Section 5.06    Severability. If any provision of this Agreement or the
application thereof to any Person or circumstance is determined by a court of
competent jurisdiction to be invalid, void or unenforceable, the remaining
provisions hereof or thereof, or the application of such provision to Persons or
circumstances or in jurisdictions other than those as to which it has been held
invalid or unenforceable, shall remain in full force and effect and shall in no
way be affected, impaired or invalidated thereby, so long as the economic or
legal substance of the transactions contemplated hereby or thereby, as the case
may be, is not affected in any manner adverse to any Party. Upon such
determination, the Parties shall negotiate in good faith in an effort to agree
upon a suitable and equitable provision to effect the original intent of the
Parties.

Section 5.07    Force Majeure. Neither Party shall be deemed in default of this
Agreement to the

                                     - 38 -
<Page>

extent that any delay or failure in the performance of its obligations under
this Agreement results from any cause beyond its reasonable control and without
its fault or negligence, such as acts of God, acts of Governmental Authority,
embargoes, epidemics, war, riots, insurrections, acts of terrorism, fires,
explosions, earthquakes, floods, unusually severe weather conditions, labor
problems or unavailability of parts, or, in the case of computer systems, any
failure in electrical or air conditioning equipment. In the event of any such
excused delay, the time for performance shall be extended for a period equal to
the time lost by reason of the delay.

Section 5.08    Headings. The article, section and paragraph headings contained
in this Agreement are for reference purposes only and shall not affect in any
way the meaning or interpretation of this Agreement.

Section 5.09    Survival of Covenants. The covenants, releases, indemnities,
representations and warranties contained in this Agreement, and liability for
the breach of any obligations contained herein, shall survive the Effective Time
and shall remain in full force and effect thereafter.

Section 5.10    Affiliates. Abbott shall cause to be performed, and hereby
guarantees the performance of, all actions, agreements and obligations set forth
herein to be performed by any member of the Abbott Group and Hospira shall cause
to be performed, and hereby guarantees the performance of, all actions,
agreements and obligations set forth herein to be performed by any member of the
Hospira Group.

Section 5.11    Waivers of Default. Waiver by either Party of any default by
the other Party of any provision of this Agreement shall not be deemed a waiver
by the waiving Party of any subsequent or other default, nor shall it prejudice
the rights of the other Party.

                                     - 39 -
<Page>

Section 5.12    Amendments. No provisions of this Agreement shall be deemed
amended, supplemented or modified unless such amendment, supplement or
modification is in writing and signed by an authorized representative of both
Parties. No provisions of this Agreement shall be deemed waived unless such
waiver is in writing and signed by the authorized representative of the Party
against whom it is sought to be enforced.

Section 5.13    Interpretation. Words in the singular shall be deemed to
include the plural and vice versa and words of one gender shall be deemed to
include the other genders as the context requires. The terms "hereof," "herein,"
and "herewith" and words of similar import shall, unless otherwise stated, be
construed to refer to this Agreement as a whole (including all of the Exhibits
hereto) and not to any particular provision of this Agreement. Article, Section,
and Exhibit references are to the Articles, Sections, and Exhibits to this
Agreement unless otherwise specified. Unless otherwise stated, all references to
any agreement shall be deemed to include the exhibits to such agreement. The
word "including" and words of similar import when used in this Agreement shall
mean "including, without limitation," unless the context otherwise requires or
unless otherwise specified. The word "or" shall not be exclusive. Unless
otherwise specified in a particular case, the word "days" refers to calendar
days. References herein to this Agreement shall be deemed to refer to this
Agreement as of the Effective Time and as it may be amended thereafter, unless
otherwise specified. References to the performance, discharge or fulfillment of
any liability in accordance with its terms shall have meaning only to the extent
such liability has terms.

Section 5.14    Advisors. Abbott may select any Tax Counsel in connection with
the Distribution, which may include Mayer, Brown, Rowe & Maw LLP, Baker &
McKenzie and McDermott, Will & Emery. Hospira acknowledges, for itself and each
Hospira Affiliate, that

                                     - 40 -
<Page>

Mayer, Brown, Rowe & Maw LLP, Baker & McKenzie and McDermott, Will & Emery have
acted only in the capacity as counsel to Abbott, and not as counsel to Hospira
or any Hospira Affiliate, in connection with this Agreement and the provisions
contemplated herein.

Section 5.15    Mutual Drafting. This Agreement shall be deemed to be the joint
work product of the Parties and any rule of construction that a document shall
be interpreted or construed against a drafter of such document shall not be
applicable.

Section 5.16    Dispute Resolution. Any and all disputes between Abbott and
Hospira arising out of any provision of this Agreement shall be resolved through
the procedures provided in the Master ADR Agreement attached hereto as Exhibit
1.

Section 5.17    Payments.

   (a)  Procedure for Requesting and Making Indemnification Payments. On the
        occurrence of an event for which a Party is entitled to receive
        indemnification hereunder, such Party (the "Indemnified Party") shall
        send the other Party (the "Indemnifying Party") an invoice requesting
        payment accompanied by a statement describing in reasonable detail the
        amount owed and the particulars relating thereto. Unless a provision in
        this Agreement specifically provides a different time for payment, the
        Indemnifying Party shall pay to the Indemnified Party any payment it
        owes to the Indemnified Party under this Agreement within thirty (30)
        days after the receipt of the invoice for such payment.

   (b)  Procedure for Making Other Payments. If a Party is responsible for any
        Tax under Section 2.01 (the "Responsible Party") and such Tax must be
        remitted by the other Party (the "Remitting Party"), the Remitting Party
        shall send the Responsible Party an invoice

                                     - 41 -
<Page>

        requesting payment accompanied by a statement describing in reasonable
        detail the amount owed and the particulars relating thereto. Unless a
        provision in this Agreement specifically provides a different time for
        payment, the Responsible Party shall pay to the Remitting Party any
        payment it owes to the Remitting Party under this Agreement no later
        than thirty (30) days before the Remitting Party must remit the Tax to
        the appropriate Tax Authority.

   (c)  Character of Payments. For Tax purposes, the Parties agree to treat any
        payment pursuant to this Agreement in the same manner as a capital
        contribution by Abbott to Hospira or an adjustment to the Contribution
        made in the last taxable period beginning before the Distribution and,
        accordingly, as not includible in the gross income of the recipient and
        not deductible by the payor. If pursuant to a Determination it is
        determined that the receipt or accrual of any payment made under this
        Agreement is subject to any Tax, the Party making such payment shall be
        responsible for the After-Tax Amount with respect to such payment. The
        failure of a Party to include an After-Tax Amount in a demand for
        payment pursuant to this Agreement shall not be deemed a waiver by the
        Party of its right to receive an After-Tax Amount with respect to such
        payment.

   (d)  Interest on Late Payments. Unless a provision in this Agreement
        specifically provides otherwise, any payment required to be made
        pursuant to this Agreement that is not made on or before the due date
        for such payment shall bear interest from the date after the due date to
        and including the date of payment at the Prime Rate plus two percent.
        Such interest shall be paid at the same time as the payment to which it
        relates. Any interest payable pursuant to this paragraph that is not
        paid when due shall bear interest at the Prime Rate plus two percent.

                                     - 42 -
<Page>

        IN WITNESS WHEREOF, the Parties have executed and delivered this
Agreement as of the day and year first written above.

                Abbott Laboratories

                By:
                    -------------------------

                    Title

                Hospira, Inc.

                By:
                    -------------------------

                    Title

                                     - 43 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}]]